<div class="chapter"><div class="chapter"><h2 class="title">CHAPTER 14. <a name="page223"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">223</span></span>Diseases of the Uvea</h2><div class="section" id="ch14lev1sec1"><h1 class="title">UVEAL DISEASES</h1>
<p class="noindent">The symptoms and signs vary considerably with the portion of the uvea affected.</p>
<div class="section" id="ch14lev2sec1"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pain:</span> Severe, deep, boring, aching pain associated with diseases of the iris and ciliary body. Pain is absent in choroidal involvement.</p></li>
<li><p class=""><span class="italic">Redness:</span> Inflammation of the iris and ciliary body causes red eye which is absent in choroidal inflammation.</p></li>
<li><p class=""><span class="italic">Visual loss:</span> It is more in choroidal disease as it affects the overlying retina.</p></li>
<li><p class=""><span class="italic">Floaters:</span> It is again more in choroidal disease due to exudation of inflammatory cells and protein into the vitreous.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec2"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Ciliary congestion:</span> It is present in inflammation of the iris and ciliary body, but absent in choroiditis.</p></li>
<li><p class=""><span class="italic">Distortion of the pupil:</span> It is due to abnormalities in the iris.</p></li>
<li><p class=""><span class="italic">Accommodation:</span> It is disturbed in ciliary body involvement.</p></li>
<li><p class=""><span class="italic">Release of cells and protein</span> occurs in anterior chamber in iris inflammation, in vitreous in choroidal inflammation; and both in the anterior chamber and vitreous cavity in ciliary body inflammation.</p></li>
<li><p class=""><span class="italic">Keratic precipitates (KPs):</span> They are seen in inflammation of the iris and ciliary body.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopic</span> abnormal signs are found more in choroidal involvement, with associated retinal signs due to chorioretinal involvement.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec2"><h1 class="title">CONGENITAL ANOMALIES</h1>
<div class="section" id="ch14lev2sec3"><h2 class="title">Anomalies of the Pupil</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Corectopia:</span> Displacement of the pupil from its normal position, usually to the nasal side (normally, the pupil is situated just nasal to the center of the cornea).</p></li>
<li><p class=""><span class="italic">Polycoria:</span> Multiple pupils—(a) true polycoria—multiple pupils, each having a sphincter muscle, are extremely rare and (b) pseudopolycoria—multiple pupils without sphincters, are common.</p></li>
<li><p class=""><span class="italic">Pear-shaped pupil:</span> It is due to coloboma of the iris.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec4"><h2 class="title">Aniridia</h2>
<p class="noindent">It is usually a bilateral condition in which the whole of the iris is appeared to be missing on external examination <bold>(<a href="#ch14fig1" class="ulink-inter">Figs. 14.1A and B</a>)</bold>.</p>
<ul style="list-style-type: bullet">
<li><p class="">The rudimentary iris, concealed behind the corneoscleral limbus, is only visible by gonioscopy.</p></li>
<li><p class="">It is due to failure of anterior growth and differentiation of the optic cup.</p></li>
</ul>
<div class="section" id="ch14lev3sec1"><h3 class="title">Symptoms</h3>
<p class="noindent">They are photophobia, nystagmus and low visual acuity (6/60 or less).<a name="page224"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">224</span></span></p>
<div class="figure" id="ch14fig1" data-label="Figs. 14.1A and B"><div class="title"><span class="item-label">Figs. 14.1A and B</span> Aniridia. <bold>A.</bold> Schematic representation; <bold>B.</bold> Photograph.</div><img alt="Figs. 14.1A and B" src="/MediumImage/224-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch14lev3sec2"><h3 class="title">Signs</h3>
<ul style="list-style-type: bullet">
<li><p class="">Ciliary processes and suspensory ligaments of the lens are visible.</p></li>
<li><p class="">Associated secondary glaucoma with glaucomatous optic atrophy in 25% of the cases. Associated foveal hypoplasia.</p></li>
<li><p class="">Total or 360° limbal stem cell deficiency (LSCD) is present in half of the cases.</p></li>
<li><p class="">Mental retardation and congenital cataract in some cases.</p></li>
<li><p class="">Aniridia and Wilms’ tumor are associated with deletion of the short arm of chromosome 11 (Miller's syndrome).</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec3"><h3 class="title">Treatment</h3>
<ul style="list-style-type: bullet">
<li><p class="">Provision of an artificial pupil by means of an iris-painted soft contact lens. This reduces photophobia, but does not improve vision.</p></li>
<li><p class="">The glaucoma responds poorly to medical and conventional surgical treatment. Glaucoma drainage devices (GDD) work better in these eyes.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch14lev2sec5"><h2 class="title">Persistent Pupillary Membrane</h2>
<p class="noindent">Pupillary membrane is the anterior vascular sheath of the lens, a fetal structure, which normally disappears shortly before birth <bold>(<a href="#ch14fig2" class="ulink-inter">Figs. 14.2A and B</a>)</bold>.</p>
<div class="figure" id="ch14fig2" data-label="Figs. 14.2A and B"><div class="title"><span class="item-label">Figs. 14.2A and B</span> <bold>A.</bold> Persistent pupillary membrane; <bold>B.</bold> Persistent pupillary membrane with anterior polar cataract.</div><img alt="Figs. 14.2A and B" src="/MediumImage/224-2.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><a name="page225"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">225</span></span>Persistent pupillary membrane is due to continued existence of part of this membrane.</p></li>
<li><p class="">This appears as fine strands of membrane, running inward from the collarette and sometimes, inserting into the anterior lens capsule or spanning the pupil. There may be associated anterior polar cataract in some eyes.</p></li>
<li><p class=""><span class="italic">It is never at the pupillary margin</span> (a point to differentiate it from the posterior synechiae which are formed at the pupillary margin).</p></li>
<li><p class="">It usually does not interfere with vision.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec6"><h2 class="title">Colobomas</h2>
<p class="noindent">Colobomas are developmental imperfect closure of the fetal fissure.</p>
<p class="indent">Consequently, they show an absence of any or all the structures of inner two layers which lie along the corresponding inferonasal sector of the eye.</p>
<p class="noindent">Coloboma may be <span class="italic">typical</span> or <span class="italic">atypical</span>.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Typical:</span> It is always found along the lower nasal sector of the eye due to imperfect closure of the fetal fissure.</p></li>
<li><p class=""><span class="italic">Atypical:</span> It is seen in other position and mainly confined to the iris <bold>(<a href="#ch14fig3" class="ulink-inter">Figs. 14.3A and B</a>)</bold>.</p></li>
</ul>
<div class="section" id="ch14lev3sec4"><h3 class="title">Typical Coloboma</h3>
<p class="noindent"><span class="italic">Genesis:</span> Overgrowth of the inner layer of the optic cup → eversion of the lips of the fetal fissure → obstruction of the natural union between the lips → failure of development of the retina and underlying structures.</p>
<p class="indent">Typical coloboma may be complete or incomplete:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Complete:</span> It extends from the pupil to the optic nerve, with a sector shaped gap, occupying about one-eighth of the circumference of the retina and choroid, ciliary body and iris, and causing a corresponding indentation of the lens where the zonular fibers are missing <bold>(<a href="#ch14fig3" class="ulink-inter">Figs. 14.3</a> and <a href="#ch14fig4" class="ulink-inter">14.4</a>)</bold>.</p>
<p class="">Complete coloboma is usually bilateral, often hereditary, and may be associated with a congenital cyst or microphthalmos.</p>
<p class=""><div class="figure" id="ch14fig3" data-label="Figs. 14.3A and B"><div class="title"><span class="item-label">Figs. 14.3A and B</span> Coloboma of the uveal tract. <bold>A.</bold> Iris coloboma; <bold>B.</bold> Choroidal coloboma.</div><img alt="Figs. 14.3A and B" src="/MediumImage/225-1.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch14fig4" data-label="Fig. 14.4"><div class="title"><span class="item-label">Fig. 14.4</span> Typical complete coloboma with cataract.</div><img alt="Fig. 14.4" src="/MediumImage/225-2.jpg"><div class="additional-markup"></div></div></p>
<p class=""><a name="page226"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">226</span></span></p>
<p class=""><div class="figure" id="ch14fig5" data-label="Fig. 14.5"><div class="title"><span class="item-label">Fig. 14.5</span> Incomplete choroidal coloboma.</div><img alt="Fig. 14.5" src="/MediumImage/226-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Incomplete:</span> When it stops short of the optic nerve, or of the iris, or else, or even partitioned by islands of normal tissue <bold>(<a href="#ch14fig5" class="ulink-inter">Figs. 14.5</a> and <a href="#ch14fig6" class="ulink-inter">14.6A</a>)</bold>.</p></li>
</ul>
<p class="noindent"><span class="italic">Typical coloboma of the iris:</span> The pupil is pear shaped with broad base toward the pupillary margin. Isolated typical coloboma of the iris is rare. It usually extends up to the ciliary body.</p>
<p class="noindent"><span class="italic">Atypical coloboma of the iris:</span> Isolated coloboma of the iris <bold>(<a href="#ch14fig6" class="ulink-inter">Fig. 14.6B</a>)</bold> is usually atypical, since the fetal fissure normally closes before the iris if formed, and it occurs at any meridian.</p>
<p class="indent">This is probably due to obstruction in the anterior growth of the optic cup by a large vessel of the fibrovascular sheath of the lens.</p>
</div>
</div>
<div class="section" id="ch14lev2sec7"><h2 class="title">Albinism</h2>
<p class="noindent">This is a hereditary disorder in which there is absence or reduction of melanin pigmentation throughout the body.</p>
<ul style="list-style-type: bullet">
<li><p class="">Albinism may be divided into two main types—<span class="italic">oculocutaneous (<a href="#ch14fig7" class="ulink-inter">Fig. 14.7</a>)</span> and <span class="italic">ocular</span>.</p></li>
<li><p class=""><span class="italic">Clinically</span>, the patient suffers from dazzling. There is associated photophobia, nystagmus, defective vision and occasionally strabismus.</p>
<p class="">Visual acuity is further lowered by high myopia and astigmatism.</p></li>
<li><p class=""><span class="italic">On examination</span>, the iris looks pink and translucent <bold>(<a href="#ch14fig8" class="ulink-inter">Fig. 14.8</a>)</bold>, owing to lack of pigment.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopically</span>, the fundus <bold>(<a href="#ch14fig9" class="ulink-inter">Fig. 14.9</a>)</bold> appears orange-pink in color. The retinal and choroidal vessels are seen with great clarity and glistening white sclera is visible in between them. Macula is also involved.</p></li>
<li><p class=""><span class="italic">Partial albinism</span> is more common, where the absence of pigment is limited to the choroid and retina. Here, the iris is brown or blue colored, and macular region may also be pigmented and looks normal. Visual acuity is much better in partial albinism.</p></li>
</ul>
<div class="figure" id="ch14fig6" data-label="Figs. 14.6A and B"><div class="title"><span class="item-label">Figs. 14.6A and B</span> <bold>A.</bold> Incomplete iris coloboma; <bold>B.</bold> Atypical iris coloboma.</div><img alt="Figs. 14.6A and B" src="/MediumImage/226-2.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page227"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">227</span></span></p>
<div class="figure" id="ch14fig7" data-label="Fig. 14.7"><div class="title"><span class="item-label">Fig. 14.7</span> Oculocutaneous albinism.</div><img alt="Fig. 14.7" src="/MediumImage/227-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig8" data-label="Fig. 14.8"><div class="title"><span class="item-label">Fig. 14.8</span> Iris transillumination.</div><img alt="Fig. 14.8" src="/MediumImage/227-2.jpg"><div class="additional-markup"></div></div>
<div class="section" id="ch14lev3sec5"><h3 class="title">Treatment</h3>
<ul style="list-style-type: bullet">
<li><p class="">As photophobia is the main symptom, dark glasses may be helpful.</p></li>
<li><p class="">Alternately, a soft contact lens with painted iris is very useful.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch14lev2sec8"><h2 class="title">Heterochromia Iridum</h2>
<p class="noindent"><span class="italic">Heterochromia iridum</span> means the two irides show a significant difference in color <bold>(<a href="#ch14fig10" class="ulink-inter">Fig. 14.10</a>)</bold>.</p>
<p class="noindent"><span class="italic">Heterochromia iridis</span> means part of the same iris, usually a sector, shows difference in color from the remainder.</p>
<div class="sidebar">
<p class="">The <span class="italic">blue iris</span> is due to absence of pigment in the iris stroma, the pigment in the retinal epithelium being seen through the translucent stroma.</p>
</div>
<p class="noindent">Heterochromic iridum may be <span class="italic">hypochromic</span> or <span class="italic">hyperchromic</span>:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Hypochromic heterochromia:</span> The eye with lighter colored iris is abnormal <bold>(<a href="#ch14fig11" class="ulink-inter">Fig. 14.11</a>)</bold></p>
<p class=""><span class="italic">Causes:</span></p>
<ul style="list-style-type: square">
<li><p class="">Simple congenital heterochromia</p></li>
<li><p class="">Horner's syndrome</p></li>
<li><p class="">Heterochromic cyclitis of Fuchs</p></li>
<li><p class="">Glaucomatocyclitic crisis</p></li>
<li><p class="">Amelanotic tumors of the iris</p></li>
<li><p class="">Iris atrophy.</p></li>
</ul></li>
</ul>
<div class="figure" id="ch14fig9" data-label="Fig. 14.9"><div class="title"><span class="item-label">Fig. 14.9</span> Fundus in albinism.</div><img alt="Fig. 14.9" src="/MediumImage/227-3.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig10" data-label="Fig. 14.10"><div class="title"><span class="item-label">Fig. 14.10</span> Heterochromia of the iris (right—blue, left—deep brown).</div><img alt="Fig. 14.10" src="/MediumImage/227-4.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page228"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">228</span></span></p>
<div class="figure" id="ch14fig11" data-label="Fig. 14.11"><div class="title"><span class="item-label">Fig. 14.11</span> Hypochromic heterochromia.</div><img alt="Fig. 14.11" src="/MediumImage/228-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig12" data-label="Fig. 14.12"><div class="title"><span class="item-label">Fig. 14.12</span> Hyperchromic heterochromia.</div><img alt="Fig. 14.12" src="/MediumImage/228-2.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Hyperchromic heterochromia:</span> The iris on the side of the disease is darker than its fellow <bold>(<a href="#ch14fig12" class="ulink-inter">Fig. 14.12</a>)</bold>.</p>
<p class=""><span class="italic">Causes:</span></p>
<ul style="list-style-type: square">
<li><p class="">Retained intraocular iron foreign body (siderosis bulbi)</p></li>
<li><p class="">Malignant melanoma of the iris</p></li>
<li><p class="">Ocular hemosiderosis (e.g., following long-standing hyphema)</p></li>
<li><p class="">Microcornea with heterochromia.</p></li>
</ul></li>
</ul>
<p class="noindent"><span class="italic">Heterochromic iridis</span>—may be congenital or acquired (iris atrophy due to herpetic uveitis, trauma, acute attack of angleclosure glaucoma, after cataract surgery, etc.).</p>
</div>
</div><div class="section" id="ch14lev1sec3"><h1 class="title">UVEITIS</h1>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Uveitis:</span> An inflammation of the uveal tract which may also involve the adjacent structures.</p></li>
<li><p class=""><span class="italic">Endophthalmitis:</span> This is a severe form of intraocular inflammation involving the ocular cavities and inner coats of the eyeball.</p></li>
<li><p class=""><span class="italic">Panophthalmitis:</span> This is the most severe form of intraocular inflammation involving the ocular cavities and all three coats of the eyeball as well as Tenon's capsule.</p></li>
</ul>
<div class="section" id="ch14lev2sec9"><h2 class="title">Classifications</h2>
<p class="noindent">The useful classifications are as follows:</p>
<div class="section" id="ch14lev3sec6"><h3 class="title">Standardization of Uveitis Nomenclature (SUN) Classification</h3>
<p class="noindent">In an effort to better organize the classification and grading of different uveitic entities, the <bold>(<a href="#ch14tbl1" class="ulink-inter">Table 14.1</a>)</bold>.</p>
<div class="table" id="ch14tbl1"><div class="title"><span class="item-label">TABLE 14.1</span> Anatomical classification of standardization of uveitis nomenclature (SUN).</div><div class="table-scroll"><table data-label="TABLE 14.1" class="download">



<thead>
<tr>
<th class="left"><p class=""><span class="italic">Type</span></p></th>
<th class="left"><p class=""><span class="italic">Primary site of inflammation</span></p></th>
<th class="left"><p class=""><span class="italic">Includes</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">Anterior uveitis</p></td>
<td class="left"><p class="">Anterior</p>
<p class="">chamber</p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Iritis</p></li>
<li><p class="">Anterior cyclitis</p></li>
<li><p class="">Iridocyclitis</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class="">Intermediate uveitis</p></td>
<td class="left"><p class="">Vitreous</p></td>
<td class="left"><p class="">Pars planitis</p></td>
</tr>
<tr>
<td class="left"><p class="">Posterior uveitis</p></td>
<td class="left"><p class="">Choroid or retina</p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Focal, multifocal or diffuse choroiditis</p></li>
<li><p class="">Chorioretinitis</p></li>
<li><p class="">Retinochoroiditis</p></li>
<li><p class="">Retinitis</p></li>
<li><p class="">Neuroretinitis</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class="">Panuveitis</p></td>
<td class="left"><p class="">Anterior chamber, vitreous, and retina or choroid</p></td>
<td class="left"></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<p class="noindent"><a name="page229"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">229</span></span>Standardization of uveitis nomenclature working group developed a process to standardize the approach to reporting clinical data for improving the consistency.</p>
<p class="noindent"><span class="italic">Onset</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Sudden</p></li>
<li><p class="">Insidious.</p></li>
</ul>
<p class="noindent"><span class="italic">Duration</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Limited:</span> Less than 3 months duration</p></li>
<li><p class=""><span class="italic">Persistent:</span> More than 3 months duration.</p></li>
</ul>
<p class="noindent"><span class="italic">Course</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Acute:</span> Sudden onset and limited duration.</p></li>
<li><p class=""><span class="italic">Recurrent:</span> Repeated episode separated by periods of inactivity without treatment more than 3 months duration.</p></li>
<li><p class=""><span class="italic">Chronic:</span> Persistent uveitis with relapse in less than 3 months, after discontinuing treatment.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec7"><h3 class="title">Activity of Uveitis Terminology</h3>
<div class="informaltable"><div class="table-scroll"><table class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Term</span></p></th>
<th class="left"><p class=""><span class="italic">Definition</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">Inactive</p></td>
<td class="left"><p class="">Grade 0 cells</p></td>
</tr>
<tr>
<td class="left"><p class="">Worsening activity</p></td>
<td class="left"><p class="">Two-step increase in level of inflammation (e.g., anterior chamber cells, vitreous haze) or increase from grade 3+ to 4+</p></td>
</tr>
<tr>
<td class="left"><p class="">Improved activity</p></td>
<td class="left"><p class="">Two-step decrease in level of inflammation (e.g., anterior chamber cells, vitreous haze) or decrease to grade 0</p></td>
</tr>
<tr>
<td class="left"><p class="">Remission</p></td>
<td class="left"><p class="">Inactive disease for more than 3 months after discontinuing all treatment for eye disease</p></td>
</tr>
</tbody>
</table></div></div>
</div>
<div class="section" id="ch14lev3sec8"><h3 class="title">Etiological Classification</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Idiopathic:</span> 25–30% of all cases.</p></li>
<li><p class=""><span class="italic">Exogenous:</span> After external injury, either by microorganisms or by other agents from outside.</p></li>
<li><p class=""><span class="italic">Endogenous:</span> Either caused by microorganisms or other agents (immune complex) from within the patient. The causes of endogenous uveitis are:
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Secondary to systemic diseases</span>
<ul style="list-style-type: dash">
<li><p class="">Seronegative arthritis</p></li>
<li><p class="">Tuberculosis, syphilis and leprosy</p></li>
<li><p class="">Sarcoidosis</p></li>
<li><p class="">Ulcerative colitis.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Secondary to infections</span>
<ul style="list-style-type: dash">
<li><p class="">Viral, e.g., herpetic</p></li>
<li><p class="">Fungal, e.g., candidiasis</p></li>
<li><p class="">Parasitic, e.g., toxoplasmosis.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Lens-induced uveitis</span></p></li>
<li><p class=""><span class="italic">Idiopathic specific uveitis</span>
<ul style="list-style-type: dash">
<li><p class="">Pars planitis</p></li>
<li><p class="">Fuchs’ heterochromic cyclitis</p></li>
<li><p class="">Sympathetic ophthalmitis.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Others</span>
<ul style="list-style-type: dash">
<li><p class="">Malignant tumors (Masquerade syndrome)</p></li>
<li><p class="">Associated with septic infection, e.g., sinusitis, otitis media, tonsillitis, etc.</p></li>
<li><p class="">Direct spread from the adjacent structures, e.g.,
<ul style="list-style-type: dash">
<li><p class="">Cornea (deep keratitis)</p></li>
<li><p class="">Sclera (scleritis)</p></li>
<li><p class="">Retina (retinitis), etc.</p></li>
</ul></p></li>
</ul></p></li>
</ul></p></li>
</ul>
<p class="indent">A number of diseases associated with uveitis occur much more frequently in those persons with certain specific HLA types, e.g.,</p>
<ul style="list-style-type: bullet">
<li><p class="">HLA–B27—in acute anterior uveitis</p></li>
<li><p class="">HLA–B5—in Behcet's disease</p></li>
<li><p class="">HLA–DR4—in VKH syndrome.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec9"><h3 class="title">Pathological Classification</h3>
<ul style="list-style-type: bullet">
<li><p class="">Granulomatous</p></li>
<li><p class="">Nongranulomatous</p></li>
</ul>
<p class="indent">The main clinical differences between the two are summarized in <bold><a href="#ch14tbl2" class="ulink-inter">Table 14.2</a></bold>.</p>
<p class="noindent"><span class="italic">Basic pathomechanisms in uveitis</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Vasodilatation</p></li>
<li><p class="">Increased capillary permeability</p></li>
<li><p class="">Migration of inflammatory cells into the ocular cavities.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch14lev1sec4"><h1 class="title">ANTERIOR UVEITIS (IRIDOCYCLITIS)</h1>
<div class="section" id="ch14lev2sec10"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pain:</span> Acute, severe pain with radiation along the branches of the 5th nerve. It is typically worse at night<a name="page230"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">230</span></span></p></li>
</ul>
<div class="table" id="ch14tbl2"><div class="title"><span class="item-label">TABLE 14.2</span> Clinical difference between granulomatous uveitis and nongranulomatous uveitis.</div><div class="table-scroll"><table data-label="TABLE 14.2" class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Granulomatous uveitis</span></p></th>
<th class="left"><p class=""><span class="italic">Nongranulomatous uveitis</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">Insidious onset and chronic course</p></td>
<td class="left"><p class="">Acute onset and short course</p></td>
</tr>
<tr>
<td class="left"><p class="">Relatively mild and white eye</p></td>
<td class="left"><p class="">Severe and red eye</p></td>
</tr>
<tr>
<td class="left"><p class="">Nodules (Keoppe's and Bussaca's) on the iris</p></td>
<td class="left"><p class="">No such nodules on the iris</p></td>
</tr>
<tr>
<td class="left"><p class="">Medium to large KPs (often mutton-fat type)</p></td>
<td class="left"><p class="">Fine keratic precipitates (KPs)</p></td>
</tr>
<tr>
<td class="left"><p class="">Mild flare</p></td>
<td class="left"><p class="">Intense flare, often with heavy fibrinous exudates</p></td>
</tr>
<tr>
<td class="left"><p class="">Anterior uvea and retina choroid are equally involved</p></td>
<td class="left"><p class="">Mainly limited to the anterior uvea</p></td>
</tr>
<tr>
<td class="left"><p class="">Tuberculosis, sarcoidosis, leprosy, etc. are usually responsible</p></td>
<td class="left"><p class="">Mainly idiopathic and immunogenic in nature</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Redness:</span> It is due to vasodilatation</p></li>
<li><p class=""><span class="italic">Photophobia</span></p></li>
<li><p class=""><span class="italic">Lacrimation</span></p></li>
<li><p class=""><span class="italic">Dimness of vision:</span> It is due to:
<ul style="list-style-type: square">
<li><p class="">Plasmoid (turbid) aqueous</p></li>
<li><p class="">Vitreous exudates</p></li>
<li><p class="">Exudates in the pupillary area</p></li>
<li><p class="">Cystoid macular edema</p></li>
<li><p class="">Secondary glaucoma</p></li>
<li><p class="">Ciliary muscle spasm</p></li>
<li><p class="">Complicated cataract.</p></li>
</ul></p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec11"><h2 class="title">Ocular Signs (<a href="#ch14fig13" class="ulink-inter">Fig. 14.13</a>)</h2>
<p class="noindent"><span class="italic">Circumcorneal ciliary congestion (CCC):</span> It is one of the hallmarks of acute anterior uveitis.</p>
<div class="section" id="ch14lev3sec10"><h3 class="title">Keratic Precipitates (<a href="#ch14fig14" class="ulink-inter">Fig. 14.14</a>)</h3>
<p class="noindent">They are cellular deposits on the corneal endothelium.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Distribution:</span> The inflammatory cells are wandering in the aqueous by convection current and stick to the edematous endothelial cells of the cornea. They arrange in a basedown triangular area at the lower part of the cornea <span class="italic">(Arlt's triangle)</span> <bold>(<a href="#ch14fig15" class="ulink-inter">Fig. 14.15</a>)</bold> due to gravitation. The smaller ones are above and the larger ones are below. However, in Fuchs’ cyclitis, they are scattered throughout the endothelium.</p></li>
</ul>
<div class="figure" id="ch14fig13" data-label="Fig. 14.13"><div class="title"><span class="item-label">Fig. 14.13</span> Signs of iridocyclitis.</div><img alt="Fig. 14.13" src="/MediumImage/230-1.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page231"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">231</span></span></p>
<div class="figure" id="ch14fig14" data-label="Fig. 14.14"><div class="title"><span class="item-label">Fig. 14.14</span> Fine to medium keratic precipitates in acute iridocyclitis.</div><img alt="Fig. 14.14" src="/MediumImage/231-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig15" data-label="Fig. 14.15"><div class="title"><span class="item-label">Fig. 14.15</span> Mutton-fat keratic precipitates (within the Arlt's triangle).</div><img alt="Fig. 14.15" src="/MediumImage/231-2.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Size:</span> The KPs may be small (fine), medium, large and <span class="italic">mutton-fat</span> types.</p></li>
<li><p class=""><span class="italic">The small and medium-size KPs</span> are due to deposition of lymphocytes and plasma cells, and they are seen in non- granulomatous or acute uveitis.</p></li>
<li><p class=""><span class="italic">The large and mutton-fat KPs</span> are due to deposition of macrophage and epithelioid cells, and they are seen in granulomatous uveitis (as in tuberculosis or sarcoidosis).</p></li>
<li><p class=""><span class="italic">Age:</span> The KPs may be fresh or old.</p></li>
<li><p class=""><span class="italic">Fresh</span> KPs are round, white, fluffy and hydrated in appearance.</p></li>
<li><p class=""><span class="italic">Old KPs</span> are shrunken, faded and become pigmented with crenated edge, and halos are seen surrounding them. Old <span class="italic">mutton-fat</span> KPs have <span class="italic">ground-glass</span> appearance.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec11"><h3 class="title">Anterior Chamber</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Aqueous flare:</span> It is due to leakage of proteins into the aqueous through the damaged capillaries, causing a Tyndall effect. It is not necessarily a sign of active uveitis, specially in absence of aqueous cells. The flare is graded <bold>(<a href="#ch14tbl3" class="ulink-inter">Table 14.3</a> and <a href="#ch14fig16" class="ulink-inter">Fig. 14.16</a>)</bold> (from 0 to 4+) depending upon the degree of obstruction of iris details under slit lamp.</p></li>
<li><p class=""><span class="italic">Aqueous cells:</span> It is due to exudation of inflammatory cells into the aqueous presence of cells in aqueous always indicates active inflammation.</p>
<p class="">The cells should be counted and <bold>(<a href="#ch14tbl4" class="ulink-inter">Table 14.4</a>)</bold> graded (from 0 to 4+) under oblique slit lamp beam (1 mm long and 1 mm wide) <bold>(<a href="#ch14fig16" class="ulink-inter">Figs. 14.16</a> and <a href="#ch14fig17" class="ulink-inter">14.17</a>)</bold>.</p></li>
</ul>
<div class="table" id="ch14tbl3"><div class="title"><span class="item-label">TABLE 14.3</span> Grading of aqueous flare.</div><div class="table-scroll"><table data-label="TABLE 14.3" class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Grades</span></p></th>
<th class="left"><p class=""><span class="italic">Description</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">0</p></td>
<td class="left"><p class="">None</p></td>
</tr>
<tr>
<td class="left"><p class="">1+</p></td>
<td class="left"><p class="">Faint</p></td>
</tr>
<tr>
<td class="left"><p class="">2+</p></td>
<td class="left"><p class="">Moderate (iris and lens details clear)</p></td>
</tr>
<tr>
<td class="left"><p class="">3+</p></td>
<td class="left"><p class="">Marked (iris and lens details hazy)</p></td>
</tr>
<tr>
<td class="left"><p class="">4+</p></td>
<td class="left"><p class="">Intense (fibrin or plastic aqueous)</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig16" data-label="Fig. 14.16"><div class="title"><span class="item-label">Fig. 14.16</span> Aqueous flare and cells.</div><img alt="Fig. 14.16" src="/MediumImage/231-3.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page232"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">232</span></span></p>
<div class="table" id="ch14tbl4"><div class="title"><span class="item-label">TABLE 14.4</span> Grading of aqueous cells.</div><div class="table-scroll"><table data-label="TABLE 14.4">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Grades</span></p></th>
<th class="left"><p class=""><span class="italic">Cells in field*</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">0</p></td>
<td class="left"><p class="">&lt;1</p></td>
</tr>
<tr>
<td class="left"><p class="">0.5+</p></td>
<td class="left"><p class="">1–5</p></td>
</tr>
<tr>
<td class="left"><p class="">1+</p></td>
<td class="left"><p class="">6–15</p></td>
</tr>
<tr>
<td class="left"><p class="">2+</p></td>
<td class="left"><p class="">16–25</p></td>
</tr>
<tr>
<td class="left"><p class="">3+</p></td>
<td class="left"><p class="">26–50</p></td>
</tr>
<tr>
<td class="left"><p class="">4+</p></td>
<td class="left"><p class="">50+</p></td>
</tr>
<tr>
<td colspan="2" class="left"><p class="small">*Field size is 1 × 1 mm slit lamp beam</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig17" data-label="Fig. 14.17"><div class="title"><span class="item-label">Fig. 14.17</span> Aqueous cells and flare more intense.</div><img alt="Fig. 14.17" src="/MediumImage/232-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Hypopyon:</span> It is classically seen in Behcet's syndrome or infectious cases (herpetic uveitis).</p></li>
<li><p class=""><span class="italic">Hyphema:</span> In herpetic and traumatic uveitis.</p></li>
<li><p class=""><span class="italic">Depth</span>
<ul style="list-style-type: square">
<li><p class="">Deep and irregular—in posterior synechiae</p></li>
<li><p class="">Funnel shaped—in iris bombe.</p></li>
</ul></p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec12"><h3 class="title">Iris</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Muddy iris or loss of iris pattern:</span> This is due to accumulation of fluid and exudates over the surface of the iris.</p></li>
<li><p class=""><span class="italic">Iris nodules:</span> It is seen in granulomatous uveitis.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Koeppe's nodule:</span> At the pupillary border, and smaller in size.</p></li>
<li><p class=""><span class="italic">Busacca's nodule (<a href="#ch14fig18" class="ulink-inter">Fig. 14.18</a>):</span> On the surface of the iris, away from the pupil.</p>
<p class=""><div class="figure" id="ch14fig18" data-label="Fig. 14.18"><div class="title"><span class="item-label">Fig. 14.18</span> Busacca's nodule.</div><img alt="Fig. 14.18" src="/MediumImage/232-2.jpg"><div class="additional-markup"></div></div></p></li>
</ul></p></li>
<li><p class=""><span class="italic">Iris atrophy and heterochromia:</span> It is seen in Fuchs’ heterochromic cyclitis and herpetic uveitis.</p></li>
<li><p class=""><span class="italic">Rubeosis iridis:</span> Iris neovascularization develops in chronic anterior uveitis and in Fuchs’ heterochromic cyclitis.</p></li>
<li><p class=""><span class="italic">Synechiae</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Posterior synechiae:</span> It is the adhesion between the anterior lens surface and the iris. This is due to organization of fibrinous exudate between the pupillary margin and the lens surface. This adhesion may be localized or diffuse.
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Ring (annular) synechiae:</span> Posterior synechiae extending for 360° around the pupil <span class="italic">(seclusio pupillae)</span>, prevent the passage of aqueous from the posterior to the anterior chamber. This gives rise to forward bowing of the peripheral iris causing an <span class="italic">iris bombe</span> <bold>(<a href="#ch14fig19" class="ulink-inter">Fig. 14.19</a>)</bold>. This may lead to elevation of intraocular pressure due to secondary angle closure by the peripheral iris <bold>(<a href="#ch14fig20" class="ulink-inter">Fig. 14.20</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Total posterior synechiae:</span> Adhesion of entire iris with the anterior lens capsule.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Anterior synechiae:</span> Adhesion of iris with the corneal endothelium. It is usually peripheral and secondary to iris bombe.<a name="page233"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">233</span></span></p>
<p class=""><div class="figure" id="ch14fig19" data-label="Fig. 14.19"><div class="title"><span class="item-label">Fig. 14.19</span> Iris bombe.</div><img alt="Fig. 14.19" src="/MediumImage/233-1.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch14fig20" data-label="Fig. 14.20"><div class="title"><span class="item-label">Fig. 14.20</span> Ring synechia with <span class="italic">iris bombe</span> in acute iridocyclitis with hypopyon.</div><img alt="Fig. 14.20" src="/MediumImage/233-2.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch14fig21" data-label="Fig. 14.21"><div class="title"><span class="item-label">Fig. 14.21</span> Healed iridocyclitis—festooned pupil.</div><img alt="Fig. 14.21" src="/MediumImage/233-3.jpg"><div class="additional-markup"></div></div></p></li>
</ul></p></li>
<li><p class="">Ectropion of the uveal pigment at the pupillary margin.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec13"><h3 class="title">Pupil</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Sluggish or non-reacting pupil:</span> This is due to edema of the iris and also due to posterior synechiae.</p></li>
<li><p class=""><span class="italic">Miotic pupil:</span> It is due to (i) water logging of the iris, (ii) toxins act on powerful sphincter pupillae, and (iii) ring synechiae.</p></li>
<li><p class=""><span class="italic">Irregular or festooned pupil:</span> Irregular dilatation of the pupil with mydriatic, and it is due to posterior synechiae <bold>(<a href="#ch14fig21" class="ulink-inter">Fig. 14.21</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Occlusio pupillae:</span> Pupil is blocked or occluded by the organized fibrinous exudates.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec14"><h3 class="title">Lens</h3>
<p class="noindent">Changes are mostly seen in chronic or healed anterior uveitis.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pigmentation</span> on the anterior surface of the lens.</p></li>
<li><p class=""><span class="italic">Complicated cataract:</span> Polychromatic luster and bread-crumb appearance at the posterior cortex.</p></li>
<li><p class=""><span class="italic">Cyclitic membrane:</span> It forms behind the lens, due to organization of the fibrinous exudates.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec15"><h3 class="title">Tension (IOP)</h3>
<ul style="list-style-type: bullet">
<li><p class="">May be normal.</p></li>
<li><p class=""><span class="italic">Decreased</span>—in acute iridocyclitis (due to acute ciliary shock).</p></li>
<li><p class=""><span class="italic">Increased</span>—in long-standing anterior uveitis (due to secondary angle-closure or may be steroid induced).</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec16"><h3 class="title">Posterior Segment</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Vitreous opacities:</span> Due to exudation and inflammatory cells in the vitreous. It is more common in cyclitis (<span class="italic">Refer</span> <bold><a href="#ch14tbl5" class="ulink-inter">Table 14.5</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Fundus changes:</span> Cystoid macular edema due to liberation of toxins. It is more with chronic anterior uveitis.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch14lev2sec12"><h2 class="title">Systemic Signs</h2>
<p class="noindent">General examination is important to find out the etiological factor, e.g., examination of skin (rash, <a name="page234"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">234</span></span>vitiligo, psoriasis), hair (poliosis, alopecia), genitourinary tract (urethritis), respiratory tract (tuberculosis), buccal mucosa (ulceration), etc.</p>
</div>
<div class="section" id="ch14lev2sec13"><h2 class="title">Sequelae and Complications of Anterior Uveitis</h2>
<ul style="list-style-type: bullet">
<li><p class="">Posterior synechiae</p></li>
<li><p class="">Ring synechiae → <span class="italic">seclusio pupillae</span> → <span class="italic">iris bombe</span> → peripheral anterior synechiae → secondary angle-closure glaucoma</p></li>
<li><p class="">Total posterior synechiae</p></li>
<li><p class=""><span class="italic">Occlusio pupillae</span></p></li>
<li><p class=""><bold>Secondary glaucoma:</bold> It is due to:
<ul style="list-style-type: square">
<li><p class="">Albuminous aqueous blocking the angle.</p></li>
<li><p class="">Associated trabeculitis and trabecular edema.</p></li>
<li><p class="">Ring synechiae → <span class="italic">iris bombe</span> → peripheral anterior synechiae → secondary angle-closure glaucoma.</p></li>
<li><p class=""><span class="italic">Occlusio pupillae</span> → anterior synechiae → secondary angle-closure glaucoma.</p></li>
<li><p class="">Steroid-induced glaucoma (due to prolonged steroid therapy).</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Cyclitic membrane:</span> It occurs more in cyclitis and forms behind the lens</p></li>
<li><p class="">Complicated cataract</p></li>
<li><p class="">Pseudoglioma, due to vitreous exudation</p></li>
<li><p class="">Cystoid macular edema</p></li>
<li><p class=""><span class="italic">Phthisis (atrophic) bulbi:</span> It prolonged cyclitis → ciliary body atrophy → less secretion of aqueous → atrophic bulbi</p></li>
<li><p class=""><span class="italic">Tractional retinal detachment:</span> It is due to traction by the cyclitic membrane</p></li>
<li><p class=""><span class="italic">Band-shaped keratopathy (BSK):</span> More common in children with juvenile (idiopathic) rheumatoid arthritis, and chronic iridocyclitis.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec14"><h2 class="title">Investigations</h2>
<ul style="list-style-type: bullet">
<li><p class="">Routine hemogram including ESR</p></li>
<li><p class=""><span class="italic">Serological tests:</span> Antinuclear antibody (ANA); rheumatoid factor (RF); HLA typing; venereal disease research laboratory (VDRL) and fluorescent treponemal antibody absorption (FTAABS) for syphilis; ELISA, etc.</p></li>
<li><p class=""><span class="italic">Skin tests:</span> (a) Mantoux test (tuberculosis) and (b) Kveim test (sarcoidosis)</p></li>
<li><p class=""><span class="italic">X-ray:</span> (a) chest—for tuberculosis and sarcoidosis, and (b) joints—arthritis group</p></li>
<li><p class=""><span class="italic">Gallium scan:</span> For sarcoidosis</p></li>
<li><p class=""><span class="italic">Urine culture:</span> Urethritis</p></li>
<li><p class=""><span class="italic">Anterior chamber paracentesis</span> for polymerase chain reaction (PCR) to diagnose organisms and cellular analysis.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec15"><h2 class="title">Treatment</h2>
<div class="section" id="ch14lev3sec17"><h3 class="title">Local</h3>
<ul style="list-style-type: bullet">
<li><p class="">Hot compress—3–4 times daily</p></li>
<li><p class="">Use dark glasses</p></li>
<li><p class=""><span class="italic">Atropine (1%) eye drop or ointment</span>—3 times daily.</p></li>
</ul>
<p class="noindent">Atropine acts in three ways:</p>
<ol style="list-style-type: decimal">
<li><p class="">By keeping the iris and ciliary body at rest.</p></li>
<li><p class="">By reducing hyperemia.</p></li>
<li><p class="">By preventing the formation of posterior synechiae and breaking down, if any already formed.</p></li>
</ol>
<p class="indent">Combined mydriatic-cycloplegics (such as phenylephrine and homatropine, or phenylephrine and tropicamide) are sometimes better in place of atropine.</p>
<p class="indent">Atropine or any other cycloplegic should be continued for at least 10–14 days after the eyes appear to be quiet (or the aqueous cells disappear), otherwise a relapse is likely to occur.</p>
<p class="indent">A powerful mydriatic effect can be obtained by subconjunctival injection of 0.3 mL mydricaine (a mixture of atropine, lignocaine and adrenaline) often called a <span class="italic">dynamite mixture</span> to break the recently formed synechiae.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Corticosteroids:</span> They are used as topical drops or ointment, or as subconjunctival or sub-Tenon injection:
<ul style="list-style-type: square">
<li><p class="">Prednisolone acetate or dexamethasone eye drops—6 hourly to 1 hourly, depending upon the severity of the inflammation.<a name="page235"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">235</span></span></p></li>
<li><p class="">Corticosteroid ointment—at bed time.</p></li>
<li><p class="">Subconjunctival injection of dexamethasone (may be mixed with injection atropine)—daily if required.</p></li>
<li><p class="">Sub-Tenon injection of long-acting steroid (triamcinolone)—every 4–6 weeks.</p></li>
</ul></p></li>
</ul>
<p class="indent">Topical steroids need to be gradually tapered off with the response. IOP monitoring is important while the patient is on steroids for a long duration.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Nonsteroidal anti-inflammatory drops:</span></p></li>
</ul>
<p class="indent">Diclofenac, indomethacin, nepafenac or flurbiprofen, 3–4 times daily when topical steroids are contraindicated.</p>
</div>
<div class="section" id="ch14lev3sec18"><h3 class="title">Systemic</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Systemic corticosteroids:</span> If the response to topical steroid is poor, oral prednisolone—1–1.5 mg/kg body weight day, is given in a tapering dose.</p></li>
<li><p class=""><span class="italic">Anti-inflammatory (nonsteroidal) drugs:</span></p>
<p class="">Like aspirin, indomethacin, diclofenac to reduce the pain and inflammation.</p></li>
<li><p class="">Systemic antibiotic or antitubercular drugs in selective cases.</p></li>
<li><p class="">Very rarely, <span class="italic">immunosuppressive</span> agents, e.g., in rheumatoid sclerouveitis.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec19"><h3 class="title">Treatment of Complications</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Secondary glaucoma:</span> Tab acetazolamide—250 mg 3–4 times daily, and/or timolol maleate (0.5%) drops twice daily.</p></li>
<li><p class=""><span class="italic">Annular synechiae:</span> Laser iridotomy.</p></li>
<li><p class=""><span class="italic">Iris bombe:</span> Laser iridotomy or 4-point iridotomy <span class="italic">(quadri-puncture)</span> with a von Graefe's cataract knife or 23G MVR blade.</p></li>
<li><p class=""><span class="italic">Cataract extraction:</span> Extracapsular extraction is done under cover of systemic and topical steroids, and atropine eye drop which are also to be continued in the post-operative periods.</p>
<p class="">A hydrophobic foldable intraocular lens implantation is preferable in post-uveitic cataract after ECCE.</p></li>
<li><p class=""><span class="italic">Band-shaped keratopathy:</span> Epithelial scraping and application of 0.1 M solution of disodium EDTA.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch14lev1sec5"><h1 class="title">INTERMEDIATE UVEITIS (PARS PLANITIS)</h1>
<div class="section" id="ch14lev2sec16"><h2 class="title">Etiology</h2>
<p class="noindent">The exact cause is still not clear. It is thought to be due to some immunological reactions at the pars plana and outer layers of the peripheral retina.</p>
</div>
<div class="section" id="ch14lev2sec17"><h2 class="title">Clinical Features</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Age:</span> Second to fourth decade.</p></li>
<li><p class=""><span class="italic">Sex:</span> It can affect either sex.</p></li>
<li><p class=""><span class="italic">Laterality:</span> It usually bilateral (80%).</p></li>
<li><p class=""><span class="italic">Incidence:</span> In 5–15% of all uveitic patients.</p></li>
<li><p class=""><span class="italic">Symptoms:</span> Floaters and blurring of vision.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec18"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Posterior segment</span>
<ul style="list-style-type: square">
<li><p class="">Inflammatory cells in the anterior vitreous.</p></li>
<li><p class="">Snow-ball opacities in the vitreous cavity.</p></li>
<li><p class="">Snow-bank exudates over the pars plana which is best seen with an indirect ophthalmoscope.</p></li>
<li><p class="">Absence of focal inflammatory lesions in the fundus.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Anterior segment:</span> It is due to spillover anterior uveitis:
<ul style="list-style-type: square">
<li><p class="">Moderate aqueous cells and flare.</p></li>
<li><p class="">Posterior synechiae.</p></li>
</ul></p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec19"><h2 class="title">Complications (Causes of Visual Loss)</h2>
<ul style="list-style-type: bullet">
<li><p class="">Complicated cataract</p></li>
<li><p class="">Cystoid macular edema (CME)</p></li>
<li><p class="">Vitreous hemorrhage</p></li>
<li><p class="">Retinal detachment (tractional).</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec20"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class="">Mild cases are self-limiting, and do not require any treatment except periodic observation.</p></li>
<li><p class="">But, in moderate to severe cases (vision less than 6/12) or in the evidence of CME, the treatment is:<a name="page236"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">236</span></span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Sub-Tenon injection of triamcinolone</span> every 4–6 weeks.</p></li>
<li><p class=""><span class="italic">Systemic steroids</span>—oral prednisolone (60 mg/day) for two weeks—then tapered off slowly.</p></li>
<li><p class=""><span class="italic">Cryotherapy</span>—if above treatment fails.</p></li>
<li><p class=""><span class="italic">Pars plana vitrectomy</span>—if cryotherapy is ineffective.</p></li>
<li><p class=""><span class="italic">Immunosuppressive agents</span>, very rarely.</p></li>
</ul></p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec6"><h1 class="title">POSTERIOR UVEITIS</h1>
<div class="section" id="ch14lev2sec21"><h2 class="title">Etiology</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Infectious:</span> Toxoplasmosis, tuberculosis, syphilis, etc.</p></li>
<li><p class="">Autoimmune.</p></li>
<li><p class="">Idiopathic.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec22"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Floaters:</span> More with peripheral lesions.</p></li>
<li><p class=""><span class="italic">Impaired vision:</span> Mainly with lesions involving the fovea and papillomacular bundle.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec23"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Anterior segment:</span> Usually normal.</p></li>
<li><p class=""><span class="italic">Posterior segment</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Vitreous</span>
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Opacities:</span> Various types of vitreous opacities, caused by inflammatory cells and exudates are:
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Fine opacities:</span> They are composed of individual inflammatory cells.</p></li>
<li><p class=""><span class="italic">Coarse opacities:</span> They are result of severe tissue destruction.</p></li>
<li><p class=""><span class="italic">Stringy opacities:</span> They are caused by alterations in the vitreous gel itself.</p></li>
<li><p class=""><span class="italic">Snow-ball opacities:</span> They are the large opacities seen in pars planitis, sarcoidosis and candidiasis.</p></li>
</ul></p></li>
</ul></p></li>
</ul></p></li>
</ul>
<p class="indent">Grading of vitreous opacities (0 to 4+) is done by assessing the density of the opacity, of the fundus with direct or indirect (better) ophthalmoscope <bold>(<a href="#ch14tbl5" class="ulink-inter">Table 14.5</a>)</bold>.</p>
<div class="table" id="ch14tbl5"><div class="title"><span class="item-label">TABLE 14.5</span> Grading of vitreous opacities.</div><div class="table-scroll"><table data-label="TABLE 14.5" class="download">



<thead>
<tr>
<th class="left"><p class=""><span class="italic">Grades</span></p></th>
<th class="left"><p class=""><span class="italic">Description</span></p></th>
<th class="left"><p class=""><span class="italic">Clinical findings</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class="">0</p></td>
<td class="left"><p class="">Nil</p></td>
<td class="left"><p class="">None</p></td>
</tr>
<tr>
<td class="left"><p class="">1</p></td>
<td class="left"><p class="">Minimal</p></td>
<td class="left"><p class="">Posterior pole clearly visible</p></td>
</tr>
<tr>
<td class="left"><p class="">2</p></td>
<td class="left"><p class="">Mild</p></td>
<td class="left"><p class="">Posterior pole details slightly hazy</p></td>
</tr>
<tr>
<td class="left"><p class="">3</p></td>
<td class="left"><p class="">Moderate</p></td>
<td class="left"><p class="">Posterior pole details very hazy</p></td>
</tr>
<tr>
<td class="left"><p class="">4</p></td>
<td class="left"><p class="">Marked</p></td>
<td class="left"><p class="">Posterior pole details barely visible</p></td>
</tr>
<tr>
<td class="left"><p class="">5</p></td>
<td class="left"><p class="">Severe</p></td>
<td class="left"><p class="">Fundal details not visible</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Fundus:</span> The lesion may be central, focal, multifocal, geographical or diffuse.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Choroiditis (<a href="#ch14fig22" class="ulink-inter">Figs. 14.22</a> and <a href="#ch14fig23" class="ulink-inter">14.23</a>):</span>
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Active lesions:</span> They are white, yellow or grayish patches with reasonably well-demarcated margins <bold>(<a href="#ch14fig23" class="ulink-inter">Fig. 14.23</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Inactive lesions:</span> They are well-defined white patches of chorioretinal atrophy with pigmented margins.</p>
<p class="">Retinal blood vessels pass over the choroiditis patch without interruption.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Retinitis:</span> They appears as white, cloudy areas with indistinct margins, sometimes difficult to differentiate from healthy retina.</p></li>
<li><p class=""><span class="italic">Vasculitis:</span> Periphlebitis is more common than periarteritis. Cellular infiltrates around the blood vessels cause perivascular cuffing.</p>
<p class=""><div class="figure" id="ch14fig22" data-label="Fig. 14.22"><div class="title"><span class="item-label">Fig. 14.22</span> Disseminated choroiditis.</div><img alt="Fig. 14.22" src="/MediumImage/236-1.jpg"><div class="additional-markup"></div></div></p>
<p class=""><a name="page237"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">237</span></span></p>
<p class=""><div class="figure" id="ch14fig23" data-label="Fig. 14.23"><div class="title"><span class="item-label">Fig. 14.23</span> Central choroiditis.</div><img alt="Fig. 14.23" src="/MediumImage/237-1.jpg"><div class="additional-markup"></div></div></p>
<p class=""><div class="figure" id="ch14fig24" data-label="Fig. 14.24"><div class="title"><span class="item-label">Fig. 14.24</span> Perivasculitis—candle-wax dripping.</div><img alt="Fig. 14.24" src="/MediumImage/237-2.jpg"><div class="additional-markup"></div></div></p>
<p class="">In severe periphlebitis, there is perivascular accumulation of granulomatous materials—called <span class="italic">candle-wax dripping</span> <bold>(<a href="#ch14fig24" class="ulink-inter">Fig. 14.24</a>)</bold>, seen in sarcoidosis.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Neovascularization:</span> It may be seen in pars planitis or sarcoidosis.</p></li>
<li><p class=""><span class="italic">Exudative retinal detachment:</span> It is seen in severe choroiditis, e.g., toxoplasmosis.</p></li>
<li><p class=""><span class="italic">Optic nerve findings:</span> It includes optic neuritis (from contagious foci) or optic atrophy (secondary to retinal damage).</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec24"><h2 class="title">Investigations</h2>
<ul style="list-style-type: bullet">
<li><p class="">Investigations for tuberculosis</p></li>
<li><p class="">Investigations for sarcoidosis</p></li>
<li><p class="">Venereal disease research laboratory (VDRL) and FTAABS for syphilis</p></li>
<li><p class="">Toxoplasma serology (Sabin-Feldman dye test, ELISA)</p></li>
<li><p class="">Enzyme-linked immunosorbent assay (ELISA) for toxocariasis.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec25"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">For specific infective etiology</span>
<ul style="list-style-type: square">
<li><p class="">Treatment for toxoplasmosis</p></li>
<li><p class="">Treatment for toxocariasis</p></li>
<li><p class="">AT drugs, etc., with systemic steroids if necessary.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Idiopathic posterior uveitis</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Systemic steroids:</span> Oral prednisolone—1–1.5 mg/kg body weight/day, then in tapering doses.</p></li>
<li><p class="">Posterior sub-Tenon injections of depot steroid.</p></li>
<li><p class="">Rarely, immunosuppressive agents.</p></li>
</ul></p></li>
</ul>
<div class="sidebar">
<h2 class="title">Panuveitis</h2>
<p class="">It is the most severe form of uveitis which involves the whole uveal tract.</p>
<p class="">Common causes are as follows:</p>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">Sympathetic ophthalmitis</p></li>
<li><p class="">Vogt-Koyanagi-Harada syndrome</p></li>
<li><p class="">Sarcoidosis</p></li>
<li><p class="">Behcet's disease.</p></li>
</ul></p>
</div>
</div>
</div><div class="section" id="ch14lev1sec7"><h1 class="title">SPECIFIC UVEITIC ENTITIES</h1>
<div class="section" id="ch14lev2sec26"><h2 class="title">Fuchs’ Heterochromic Cyclitis</h2>
<p class="noindent">It is a chronic, nongranulomatous anterior uveitis with insidious onset.</p>
<p class="noindent">It is usually unilateral and affects middleaged adult.</p>
<div class="section" id="ch14lev3sec20"><h3 class="title">Symptoms</h3>
<p class="noindent">Most of the patients are asymptomatic until the development of complicated cataract.</p>
</div>
<div class="section" id="ch14lev3sec21"><h3 class="title">Signs</h3>
<ul style="list-style-type: bullet">
<li><p class="">Fine stellete KPs are scattered throughout the entire endothelium.</p></li>
<li><p class="">A faint aqueous flare and cells.<a name="page238"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">238</span></span></p></li>
<li><p class="">Posterior synechiae are typically absent.</p></li>
<li><p class="">Diffuse iris stromal atrophy.</p></li>
<li><p class=""><span class="italic">Heterochromia</span> of the affected eye is usually hypochromic.</p></li>
<li><p class=""><span class="italic">Mydriasis:</span> It is due to atrophy of sphincter pupillae.</p></li>
<li><p class="">Fine neovascularization of the iris and at the angle <span class="italic">(Amsler's sign:</span> Bleeding from these new fine vessels following anterior chamber paracentesis).</p></li>
<li><p class="">Vitreous may have cells.</p></li>
</ul>
<p class="noindent"><span class="italic">Complications:</span> Two main complications—(i) cataract and (ii) glaucoma.</p>
</div>
<div class="section" id="ch14lev3sec22"><h3 class="title">Treatment</h3>
<ul style="list-style-type: bullet">
<li><p class="">Topical corticosteroids in active stage.</p></li>
<li><p class="">Mydriatics are unnecessary.</p></li>
<li><p class="">Phacoemulsification with intraocular lens (phaco with IOL) implantation can be done safely for cataract with good prognosis.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch14lev1sec8"><h1 class="title">UVEITIS IN JUVENILE RHEUMATOID ARTHRITIS</h1>
<p class="noindent">Juvenile (idiopathic) rheumatoid arthritis (JRA) is a seronegative inflammatory arthritis developing in children below 16 years of age.</p>
<p class="noindent"><span class="italic">It is classified as:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Systemic onset JRA <span class="italic">(Still's disease):</span> Uveitis is extremely rare.</p></li>
<li><p class=""><span class="italic">Polyarticular JRA:</span> Uveitis is fairly rare.</p></li>
<li><p class=""><span class="italic">Pauciarticular JRA:</span> Uveitis develops in about 20% of the cases.</p></li>
</ul>
<p class="noindent">Anterior uveitis in JRA is chronic <bold>(<a href="#ch14fig25" class="ulink-inter">Fig. 14.25</a>)</bold>, nongranulomatous, usually bilateral and mostly affecting the girls.</p>
<p class="noindent"><span class="italic">Symptoms:</span> Asymptomatic at the onset, but later, vision is impaired due to complications.</p>
<div class="section" id="ch14lev2sec27"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Eye is typically white <span class="italic">(white iritis)</span> even in presence of severe inflammation.</p></li>
<li><p class="">Small to medium size KPs.</p></li>
<li><p class="">Posterior synechiae are very common.</p></li>
<li><p class="">Pigment deposition on the lens surface.</p></li>
</ul>
<div class="figure" id="ch14fig25" data-label="Fig. 14.25"><div class="title"><span class="item-label">Fig. 14.25</span> Chronic uveitis in idiopathic rheumatoid arthritis with band-shaped keratopathy (BSK) and complicated cataract after surgery.</div><img alt="Fig. 14.25" src="/MediumImage/238-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch14lev2sec28"><h2 class="title">Complications</h2>
<ul style="list-style-type: bullet">
<li><p class="">Complicated cataract</p></li>
<li><p class="">Secondary glaucoma</p></li>
<li><p class="">Band-shaped keratopathy (common)</p></li>
<li><p class="">Ultimately, phthisis bulbi.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec29"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class="">Topical steroids and cycloplegics.</p></li>
<li><p class="">Sub-Tenon injection of depot steroids.</p></li>
<li><p class=""><span class="italic">Oral prednisolone in selective cases:</span> This is to be used with caution as it can affect the growth and bone formation of the young patients.</p></li>
<li><p class="">Cataract surgery is best done by pars plana lensectomy with vitrectomy.</p></li>
</ul>
<div class="sidebar">
<h2 class="title">Reiter's Syndrome</h2>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">It consists of a triad of urethritis, conjunctivitis and seronegative arthritis.</p></li>
<li><p class="">Uveitis is typically unilateral, acute and non- granulomatous.</p></li>
<li><p class=""><span class="italic">Treatment:</span> Topical steroids and cycloplegics.</p></li>
</ul></p>
</div>
</div>
</div><div class="section" id="ch14lev1sec9"><h1 class="title">UVEITIS IN HERPES ZOSTER</h1>
<ul style="list-style-type: bullet">
<li><p class="">The iridocyclitis is usually (hyper) acute, non-granulomatous type with small KPs.</p></li>
<li><p class="">Associated severe iris ischemia causes hypopyon which may be mixed with blood.<a name="page239"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">239</span></span></p></li>
<li><p class="">Sectorial iris atrophy with distortion of the pupil in 20% cases.</p></li>
<li><p class=""><span class="italic">Complications:</span> Secondary glaucoma, complicated cataract and very rarely phthisis bulbi (due to ciliary body ischemia) may occur.</p></li>
<li><p class=""><span class="italic">Treatment:</span> Vigorously with topical steroids, cycloplegics and if necessary with systemic steroids.</p></li>
</ul>
</div><div class="section" id="ch14lev1sec10"><h1 class="title">TUBERCULAR UVEITIS</h1>
<p class="noindent">It is usually a chronic, granulomatous uveitis. It may be non-granulomatous anterior or posterior uveitis (choroiditis), or vasculitis (Eales’ disease) depending upon the immunological status of the patient.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Anterior uveitis:</span> Classically, it is a granulomatous type of uveitis with large muttonfat KPs. It is usually bilateral, though the second eye may be affected after a few months.</p></li>
<li><p class=""><span class="italic">Posterior uveitis:</span> Commonly, it occurs as a focal or multifocal choroiditis. Rarely, a large choroidal granuloma may be seen in the fundus.</p></li>
</ul>
<div class="section" id="ch14lev2sec30"><h2 class="title">Investigations</h2>
<ul style="list-style-type: bullet">
<li><p class="">X-ray chest, complete hemogram including ESR and Mantoux test</p></li>
<li><p class=""><span class="italic">Therapeutic (Isoniazid) test:</span> A therapeutic trial of 300 mg/day isoniazid for 3 weeks is reliable. If this causes a dramatic improvement the diagnosis of tuberculosis is highly likely.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec31"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class="">Topical steroids and cycloplegics.</p></li>
<li><p class="">Full course of AT drugs.</p></li>
<li><p class="">Physician or chest specialist consultation.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec11"><h1 class="title">SARCOID UVEITIS</h1>
<p class="noindent">Sarcoid is a multisystem disorder of unknown etiology, commonly affecting young adults, and usually presents with bilateral hilar lymphadenopathy and oculocutaneous lesions.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Ocular findings are</span>—keratoconjunctivitis sicca, conjunctival granuloma and uveitis.</p></li>
<li><p class=""><span class="italic">Uveitis:</span> It may be anterior, posterior or panuveitis.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Anterior uveitis</span>
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Acute granulomatous:</span> It is seen in young patients with acute sarcoidosis.</p></li>
<li><p class=""><span class="italic">Chronic granulomatous:</span> It usually bilateral and seen among old patients. Busacca's nodules are more frequently seen than Koeppe's nodules, with typical ‘mutton-fat’ KPs. Band-shaped keratopathy (BSK), complicated cataract and glaucoma are frequent complications.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Posterior uveitis</span>
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Snow-ball</span> opacities in the vitreous.</p></li>
<li><p class="">Peripheral retinal periphlebitis with candle-wax drippings.</p></li>
<li><p class="">Retinal neovascularization at the periphery.</p></li>
<li><p class="">Preretinal nodules (sarcoid nodules), mostly located inferiorly and anterior to the equator <span class="italic">(Lander's sign)</span>.</p></li>
<li><p class="">Optic neuritis, optic nerve granuloma, optic disc neovascularization may also be seen.</p></li>
</ul></p></li>
</ul></p></li>
</ul>
<div class="section" id="ch14lev2sec32"><h2 class="title">Investigations</h2>
<ul style="list-style-type: bullet">
<li><p class="">X-ray chest—hilar lymphadenopathy</p></li>
<li><p class="">Serum angiotensin converting enzyme (ACE) usually elevated</p></li>
<li><p class="">Serum calcium—raised</p></li>
<li><p class="">Kveim test</p></li>
<li><p class="">Gallium-67 scan of the head and neck.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec33"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Anterior uveitis:</span> Topical steroids and cycloplegics.</p></li>
<li><p class=""><span class="italic">Posterior uveitis:</span> Systemic steroids and posterior sub-Tenon injection of depot steroids.</p></li>
</ul>
<p class=""><a name="page240"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">240</span></span></p>
</div>
</div><div class="section" id="ch14lev1sec12"><h1 class="title">TOXOPLASMOSIS</h1>
<p class="noindent">Toxoplasmosis is an infestation by an intra- cellular protozoan parasite, <span class="italic">Toxoplasma gondii.</span></p>
<p class="indent">The cat is the definitive host of the parasite, and human can be infested by three ways:</p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Ingestion of under-cooked meat</span> by eating the flesh of intermediate host like pig, sheep, cattle, etc.</p></li>
<li><p class=""><span class="italic">Ingestion of oocyte</span> via feces of pet cat.</p></li>
<li><p class=""><span class="italic">Transplacental</span> from infested pregnant mother to the fetus.</p></li>
</ol>
<p class="noindent"><span class="italic">Toxoplasmic uveitis may be:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Congenital posterior toxoplasmic lesions.</p></li>
<li><p class="">Recurrent toxoplasmic retinochoroiditis.</p></li>
</ul>
<div class="sidebar">
<p class=""><span class="italic">Acquired toxoplasmosis:</span> It does not cause any ocular lesion, and usually remains subclinical. All the cases of toxoplasmic uveitis in adults are due to recurrence of an old healed congenital chorioretinitis.</p>
</div>
<div class="section" id="ch14lev2sec34"><h2 class="title">Congenital Toxoplasmosis</h2>
<ul style="list-style-type: bullet">
<li><p class="">Transplacental transmission occurs only when the mother is infested during the pregnancy. But if the mother is infested before pregnancy the fetus will not be affected.</p></li>
<li><p class="">The ‘three Cs’ of congenital toxoplasmosis are: <span class="italic">chorioretinitis, convulsions and calcification</span>.</p></li>
<li><p class="">Most cases are subclinical. In these children, bilateral <bold>(<a href="#ch14fig26" class="ulink-inter">Figs. 14.26A and B</a>)</bold> healed chorioretinal scars are usually detected in later life.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec35"><h2 class="title">Recurrent Toxoplasmosis</h2>
<ul style="list-style-type: bullet">
<li><p class="">The recurrence usually takes place between the age of 10–35 years.</p></li>
<li><p class="">The primary lesion is a retinitis, and the inflammatory reactions seen in choroid, iris and retinal vessels are believed to be immunological in origin.</p>
<p class=""><span class="italic">Clinical features of recurrent lesions:</span></p></li>
</ul>
<p class="noindent"><span class="italic">Symptoms:</span> Visual loss due to:</p>
<ul style="list-style-type: bullet">
<li><p class="">Opacities in the media.</p></li>
<li><p class="">Direct involvement of the fovea.</p></li>
<li><p class="">Involvement of the papillomacular bundle and rarely the optic nerve head.</p></li>
<li><p class="">Cystoid macular edema.</p></li>
</ul>
<p class="noindent"><span class="italic">Signs</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Severe vitritis</span> resulting in inflammatory cells in the vitreous.</p></li>
<li><p class=""><span class="italic">Focal necrotizing retinitis</span> is a satellite lesion adjacent to the edge of the old scar. Active retinitis is a white or yellowish white lesion with fluffy indistinct edges at the postequatorial fundus.</p></li>
<li><p class=""><span class="italic">Deep retinitis</span> is less common.</p></li>
<li><p class=""><span class="italic">Papillitis</span> sometimes, the active retinitis is located adjacent to the optic nerve (juxtapapillary choroiditis of Jensen), or occasionally on the optic nerve head itself.</p></li>
</ul>
<div class="figure" id="ch14fig26" data-label="Figs. 14.26A and B"><div class="title"><span class="item-label">Figs. 14.26A and B</span> Bilateral congenital toxoplasmosis.</div><img alt="Figs. 14.26A and B" src="/MediumImage/240-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><a name="page241"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">241</span></span>Occasionally, there is an associated anterior uveitis.</p></li>
</ul>
<div class="section" id="ch14lev3sec23"><h3 class="title">Complications</h3>
<ul style="list-style-type: bullet">
<li><p class="">Cystoid macular edema</p></li>
<li><p class="">Subretinal neovascularization</p></li>
<li><p class="">Tractional retinal detachment.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec24"><h3 class="title">Diagnosis</h3>
<ul style="list-style-type: bullet">
<li><p class="">Sabin dye test</p></li>
<li><p class="">Fluorescent antibody (FA) test</p></li>
<li><p class="">ELISA for toxoplasma antibody.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec25"><h3 class="title">Management</h3>
<p class="noindent">Treatment is indicated only when the retinitis is severe and threatening the macula or optic nerve head.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Steroids:</span> They should not be given (in any form) alone, and it should be combined with anti-toxoplasmic drugs.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Topical:</span> In associated anterior uveitis.</p></li>
<li><p class=""><span class="italic">Posterior sub-Tenon injection:</span> In retinochoroiditis.</p></li>
<li><p class=""><span class="italic">Systemic (oral):</span> In presence of severe vitritis or in vision-threatening lesions.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Systemic anti-toxoplasmic drugs</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Sulphonamides:</span> Sulfadiazine or triple sulfa (sulfadiazine/sulfamerazine/sulfamethazine)—2.0 g loading dose, then 1 g 4 times daily for 3–4 weeks.</p></li>
<li><p class=""><span class="italic">Clindamycin:</span> Orally 300 mg, 4 times daily for 3 weeks.</p></li>
<li><p class=""><span class="italic">Pyrimethamine:</span> 75–100 mg loading dose, followed by 25 mg daily for 3–4 weeks.</p>
<p class="">If it is combined with clindamycin, only 1-week course will then be necessary. Pyrimethamine is a <span class="italic">folic acid antagonist</span>, which may cause thrombocytopenia and leucocytopenia. So, <span class="italic">folinic acid</span>, 10 mg/day, orally (mixed with orange juice) is to be added with pyrimethamine.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Minocycline:</span> 100 mg once or twice daily for 4 weeks.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch14lev1sec13"><h1 class="title">TOXOCARIASIS</h1>
<p class="noindent"><span class="italic">Toxocara</span> is an intestinal round worm of cats <span class="italic">(Toxocara cati)</span> and dogs <span class="italic">(Toxocara canis)</span>. Human ocular toxocariasis is caused by accidental ingestion of food contaminated by feces of pet cat or dog.</p>
<ul style="list-style-type: bullet">
<li><p class="">It usually presents between the age of 2 and 9 years with leukocoria, squinting or unilateral loss of vision.</p></li>
<li><p class=""><span class="italic">Signs include</span> chronic endophthalmitis, vitreous clouding and severe cyclitic membrane formation.</p></li>
<li><p class="">Toxacara endophthalmitis is considered in differential diagnosis of retinoblastoma where there is an associated secondary glaucoma.</p></li>
<li><p class="">Diagnosis is confirmed by ELISA.</p></li>
<li><p class=""><span class="italic">Treatment:</span> (a) Anthelminthic drugs (thiabendazole); (b) Pars plana vitrectomy in case of pseudoglioma formation.</p></li>
</ul>
</div><div class="section" id="ch14lev1sec14"><h1 class="title">BEHÇET'S DISEASE</h1>
<p class="noindent">It is accompanied by recurrent oral ulceration, genital ulceration, skin lesions together with neurological and articular manifestations.</p>
<ul style="list-style-type: bullet">
<li><p class="">Conjunctivitis, episcleritis and keratitis are seen in a few patients.</p></li>
<li><p class=""><span class="italic">Fundus shows:</span> Vitritis, retinal vasculitis, focal area of retinal necrosis, macular edema and optic neuropathy.</p></li>
<li><p class="">Visual prognosis is poor, and is due to phthisis bulbi or secondary optic atrophy.</p></li>
<li><p class=""><span class="italic">Treatment</span>
<ul style="list-style-type: square">
<li><p class="">Topical and systemic steroids</p></li>
<li><p class="">Oral chlorambucil for prolonged period.</p></li>
</ul></p></li>
</ul>
</div><div class="section" id="ch14lev1sec15"><h1 class="title">VOGT-KOYANAGI-HARADA SYNDROME</h1>
<ul style="list-style-type: bullet">
<li><p class="">Vogt-Koyanagi-Harada (VKH) syndrome is a severe panuveitis associated with cutaneous, neurological and auditory involvement.</p></li>
<li><p class="">It is more common in Japanese patients who have an increased prevalence of HLA-DR4 and HLA-DR53.<a name="page242"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">242</span></span></p></li>
</ul>
<div class="figure" id="ch14fig27" data-label="Fig. 14.27"><div class="title"><span class="item-label">Fig. 14.27</span> Vogt-Koyanagi-Harada syndrome (left eye).</div><img alt="Fig. 14.27" src="/MediumImage/242-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Extraocular lesions</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Cutaneous</span>—alopecia, vitiligo and poliosis <bold>(<a href="#ch14fig27" class="ulink-inter">Fig. 14.27</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Neurological</span>—headache, convulsion and cranial nerve palsy.</p></li>
<li><p class=""><span class="italic">Auditory</span>—tinnitus, vertigo and deafness.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Ocular lesions (<a href="#ch14fig28" class="ulink-inter">Fig. 14.28</a>)</span>
<ul style="list-style-type: square">
<li><p class="">A granulomatous iridocyclitis</p></li>
<li><p class="">Multifocal exudative choroiditis</p></li>
<li><p class="">Exudative retinal detachment</p></li>
<li><p class="">Optic neuritis in some cases.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Treatment</span>
<ul style="list-style-type: square">
<li><p class="">Anterior uveitis—topical steroids and cycloplegics.</p></li>
<li><p class="">Exudative retinal detachment—usually subsides after systemic corticosteroid therapy.</p></li>
</ul></p></li>
</ul>
<div class="figure" id="ch14fig28" data-label="Fig. 14.28"><div class="title"><span class="item-label">Fig. 14.28</span> Uveitis in Vogt-Koyanagi-Harada syndrome—note poliosis of the eyelashes.</div><img alt="Fig. 14.28" src="/MediumImage/242-2.jpg"><div class="additional-markup"></div></div>
</div><div class="section" id="ch14lev1sec16"><h1 class="title">SYMPATHETIC OPHTHALMITIS</h1>
<p class="noindent">It is a rare, <span class="italic">bilateral</span> granulomatous panuveitis that occurs following a penetrating injury or surgical trauma.</p>
<ul style="list-style-type: bullet">
<li><p class="">The traumatized eye is called <span class="italic">exciting eye</span>, and the fellow eye which also develops uveitis is called <span class="italic">sympathizing eye</span>.</p></li>
<li><p class="">Eighty percent cases of sympathetic ophthalmitis occur within 3 months, and 90% of cases occur within 1 year after trauma.</p></li>
</ul>
<div class="section" id="ch14lev2sec36"><h2 class="title">Symptoms (Insidious Onset)</h2>
<p class="noindent">Initial symptoms in the <span class="italic">sympathizing eye</span> are pain, photophobia, and difficulty in near vision due to loss of accommodation. In the <span class="italic">exciting eye</span> there is also pain, irritation and redness.</p>
</div>
<div class="section" id="ch14lev2sec37"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">In the <span class="italic">exciting eye</span> there is ciliary congestion and evidence of initial insult.</p></li>
<li><p class="">In the <span class="italic">sympathizing eye</span>
<ul style="list-style-type: square">
<li><p class="">Earliest feature is <span class="italic">retrolental flare</span>.</p></li>
<li><p class="">Typical granulomatous uveitis with mutton-fat KPs, iris nodules, posterior synechiae and secondary glaucoma.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Posterior segment shows:</span> (i) Small, deep, yellow-white spots <bold>(Dalen-Fuchs’ nodules)</bold> scattered throughout the fundus and (ii) perivasculitis and retinal edema.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec38"><h2 class="title">Complications</h2>
<p class="noindent">Cataract, secondary glaucoma, and eventual blindness from phthisis bulbi may occur in many cases.</p>
</div>
<div class="section" id="ch14lev2sec39"><h2 class="title">Etiopathogenesis</h2>
<p class="noindent">Sympathetic ophthalmitis almost always results from a penetrating injury. Wounds in the ciliary region <span class="italic">(dangerous zone</span> of the eye) involving the ciliary body, and its <a name="page243"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">243</span></span>incarceration in the scar, are considered especially dangerous. It very rarely occurs if actual suppuration has taken place in the <span class="italic">exciting eye</span>.</p>
<p class="indent">It is an autoimmune reaction to antigens in uveal tissue, uveal pigments or retinal antigen (retinal-S antigen).</p>
</div>
<div class="section" id="ch14lev2sec40"><h2 class="title">Pathology</h2>
<p class="noindent">Histopathology is similar in both the exciting and sympathizing eye.</p>
<ul style="list-style-type: bullet">
<li><p class="">Nodular aggregation of lymphocytes and plasma cells scattered throughout the uveal tract.</p></li>
<li><p class="">Pigment epithelium of the iris, ciliary body and choroid proliferates, and along with epithelioid cells and macrophages, they form the nodules called <span class="italic">Dalen-Fuchs</span>’ nodules.</p></li>
<li><p class="">Retina also becomes heavily infiltrated with lymphocytes and plasma cells.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec41"><h2 class="title">Treatment</h2>
<div class="section" id="ch14lev3sec26"><h3 class="title">Therapeutic</h3>
<ul style="list-style-type: bullet">
<li><p class="">Intensive therapy with topical, sub-Tenon injections and systemic corticosteroids. Systemic steroids are given in high doses (80–100 mg/day) and are gradually tapered, once the uveitis is controlled.</p></li>
<li><p class="">Immunosuppressive agents in steroid- resistant cases.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec27"><h3 class="title">Preventive</h3>
<ul style="list-style-type: bullet">
<li><p class="">Prompt and meticulous closure of all penetrating injury.</p></li>
<li><p class="">If the injured eye is unsalvageable, enucleation should be done within 2 weeks following injury.</p></li>
<li><p class="">Beneficial effect of enucleation of the exciting eye, after the development of sympathetic ophthalmitis is controversial.</p></li>
<li><p class="">Many surgeons prefer enucleation of the exciting eye within 2 weeks of the onset of sympathetic ophthalmia, as it favorably affects the eventual prognosis of the sympathizing eye.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch14lev1sec17"><h1 class="title">GLAUCOMATOCYCLITIC CRISIS (POSNER-SCHLOSSMAN SYNDROME)</h1>
<p class="noindent">Glaucomatocyclitic crisis is characterized by acute or subacute attacks of secondary open- angle glaucoma associated with mild anterior uveitis.</p>
<p class="indent">The disease affects the young adults and usually unilateral. During an attack, the intra- ocular pressure is usually severely elevated (40–60 mm of Hg), and lasts for few hours to few days.</p>
<div class="section" id="ch14lev2sec42"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class="">Colored halos around the light</p></li>
<li><p class="">Diminution of vision</p></li>
<li><p class="">Mild headache, but pain is rare.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec43"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Corneal epithelial edema</p></li>
<li><p class="">Fine nonpigmented KPs</p></li>
<li><p class="">Normal anterior chamber depth</p></li>
<li><p class="">Aqueous cells and flare</p></li>
<li><p class="">Posterior synechiae formation are rare.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec44"><h2 class="title">Differential Diagnosis</h2>
<p class="noindent">The condition is to be differentiated from acute attack of angle-closure glaucoma, as the treatment with atropine would be disastrous in a case of angle-closure glaucoma.</p>
<p class="indent">A normal depth of anterior chamber and presence of few KPs establish the diagnosis of glaucomatocyclitic crisis.</p>
</div>
<div class="section" id="ch14lev2sec45"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class="">Topical steroids and cycloplegics</p></li>
<li><p class="">Secondary glaucoma is usually treated with tablet acetazolamide, and timolol maleate drops.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec18"><h1 class="title">CYTOMEGALOVIRUS RETINITIS (<a href="#ch14fig29" class="ulink-inter">FIG. 14.29</a>)</h1>
<p class="noindent">It is a rare chronic diffuse exudative lesion of the retina caused by cytomegalovirus (CMV) which occurs in immuno-compromized patient, e.g.,<a name="page244"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">244</span></span></p>
<div class="figure" id="ch14fig29" data-label="Fig. 14.29"><div class="title"><span class="item-label">Fig. 14.29</span> Cytomegalovirus retinitis—central retinal venous occlusion.</div><img alt="Fig. 14.29" src="/MediumImage/244-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">Acquired immuno-deficiency syndrome (AIDS)</p></li>
<li><p class="">Cytotoxic chemotherapy</p></li>
<li><p class="">Long-term immunosuppression following renal transplantation.</p></li>
</ul>
<div class="section" id="ch14lev2sec46"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Scattered white patches with perivascular sheathing.</p></li>
<li><p class="">Full thickness hemorrhagic retinal necrosis with edema sometimes described as ‘pizza pie retinopathy’ or cottage cheese with ketchup appearance at the posterior pole.</p></li>
<li><p class="">Ultimately, whole retina is involved with subsequent retinal atrophy.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec47"><h2 class="title">Treatment</h2>
<p class="noindent">Intravenous injection of gancyclovir or foscarnet may cause regression in some cases.</p>
</div>
</div><div class="section" id="ch14lev1sec19"><h1 class="title">ONCHOCERCIASIS (RIVER BLINDNESS)</h1>
<ul style="list-style-type: bullet">
<li><p class="">It is caused by a filarial worm <span class="italic">Onchocerca volvulus</span>.</p></li>
<li><p class="">The vector is the blood-sucking black fly <span class="italic">Simulium</span>.</p></li>
<li><p class="">Onchocerciasis is mainly seen in endemic areas of African countries.</p></li>
<li><p class=""><span class="italic">Ocular lesions</span> are sclerosing keratitis, retinitis and anterior uveitis.</p></li>
<li><p class="">Iridocyclitis and chorioretinitis are the <span class="italic">cause of blindness</span> due to onchocerciasis.</p></li>
<li><p class=""><span class="italic">Specific therapy</span> of onchocerciasis is diethylcarbamazine (for microfilaria) and suramin (for adult worm).</p></li>
<li><p class=""><span class="italic">Ivermectin is now the drug of choice</span> for the treatment.</p></li>
<li><p class="">Onchocerciasis is included in Vision-2020 programme <span class="italic">(see</span> <a href="/9789356963825/chapter/ch26" class="ulink-exter">Chapter 26</a>).</p></li>
</ul>
</div><div class="section" id="ch14lev1sec20"><h1 class="title">PRESUMED OCULAR HISTOPLASMOSIS SYNDROME</h1>
<p class="noindent">This syndrome has been related to <span class="italic">Histoplasma capsulatum</span> infection. It is presumed because:</p>
<ul style="list-style-type: bullet">
<li><p class="">Presumed ocular histoplasmosis syndrome (POHS) has never been reported in patients with active systemic histoplasmosis.</p></li>
<li><p class="">The organism, <span class="italic">H. capsulatum</span> has not been recovered from an eye with POHS.</p></li>
<li><p class="">Histoplasmin skin test is positive in 90% of patients with POHS.</p></li>
<li><p class="">Increased prevalence of POHS, where histoplasmosis is endemic, e.g., Mississippi-Ohio-Missouri river valley.</p></li>
</ul>
<div class="section" id="ch14lev2sec48"><h2 class="title">Symptoms</h2>
<p class="noindent">It is asymptomatic unless it involves the macula, and the earliest symptom of macular involvement is metamorphopsia.</p>
</div>
<div class="section" id="ch14lev2sec49"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Atrophic mid-peripheral spots called <span class="italic">histospots</span>.</p></li>
<li><p class="">Peripapillary atrophy.</p></li>
<li><p class="">Linear chorioretinal atrophy.</p></li>
<li><p class="">Subretinal choroidal neovascularization, resulting in hemorrhagic disciform lesion at the macula.</p></li>
<li><p class="">The vitreous is never involved.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec50"><h2 class="title">Treatment</h2>
<p class="noindent">Retinal-laser photocoagulation of subretinal neovascular membranes is advised to prevent the formation of disciform macular scar.<a name="page245"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">245</span></span></p>
</div>
</div><div class="section" id="ch14lev1sec21"><h1 class="title">ACUTE RETINAL NECROSIS</h1>
<p class="noindent">Acute retinal necrosis (ARN) is an extremely rare devastating necrotizing retinitis, affecting the otherwise healthy individuals.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Symptoms</span> are periorbital pain followed by blurring of vision.</p></li>
<li><p class=""><span class="italic">Signs</span> are noticed either at the posterior pole or at the periphery of the fundus:
<ul style="list-style-type: square">
<li><p class="">Deep, multifocal, yellowish white patches with sheathing of the vessels.</p></li>
<li><p class="">The lesions gradually become confluent and represent a full thickness necrotizing retinitis.</p></li>
<li><p class="">Most of the eyes develop retinal holes, with rhegmatogenous retinal detachment.</p></li>
<li><p class="">It usually resolves within 4–12 weeks, leaving behind atrophic retinal areas. In some eyes, visual acuity remains fairly good despite severe necrosis.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Treatment:</span> Systemic antibiotics, steroids, and cytotoxic agents may be beneficial.</p></li>
</ul>
</div><div class="section" id="ch14lev1sec22"><h1 class="title">ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)</h1>
<p class="noindent">Human immunodeficiency virus (HIV) is the causative organism of this invariably fatal disease.</p>
<p class="indent">Ocular complications occur in about 75% of AIDS patients and almost all ocular structures are affected.</p>
<p class="indent">The lesions are due to retinal microvasculopathy, occurrence of Kaposi's sarcoma and opportunistic superinfections by <span class="italic">Pneumocystis carinii</span>, <span class="italic">Toxoplasma</span>, CMV, herpes zoster virus (HZV), <span class="italic">Candida</span>, molluscum contagiosum, etc.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Retinal microvasculopathy</span>
<ul style="list-style-type: square">
<li><p class="">Cotton wool spots are the most common ocular lesion and are seen in 50% of the patients <bold>(<a href="#ch14fig30" class="ulink-inter">Fig. 14.30</a>)</bold>.</p></li>
<li><p class="">They are probably due to immune complex deposits in the precapillary arterioles.</p></li>
<li><p class="">They appear as discrete fluffy opacities and are transient.</p></li>
<li><p class="">Superficial and deep hemorrhages are seen in some patients.</p>
<p class=""><div class="figure" id="ch14fig30" data-label="Fig. 14.30"><div class="title"><span class="item-label">Fig. 14.30</span> Cotton wool spots in retinal micro-vasculopathies in AIDS.</div><img alt="Fig. 14.30" src="/MediumImage/245-1.jpg"><div class="additional-markup"></div></div></p></li>
</ul></p></li>
<li><p class=""><span class="italic">Kaposi's sarcoma</span>
<ul style="list-style-type: square">
<li><p class="">It involves the eyelids and conjunctiva.</p></li>
<li><p class="">It appears as a bright-red mass, most frequently in the lower fornix of the conjunctiva.</p></li>
<li><p class="">When it affects the lid, it can lead to entropion, trichiasis, blepharoconjunctivitis, etc.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Opportunistic infections</span>
<ul style="list-style-type: square">
<li><p class="">Cytomegalovirus retinitis is the most common opportunistic infection and the major cause of visual loss in AIDS patients. Its appearance is a grave prognostic sign as most of the patients will die within 6–8 weeks</p></li>
<li><p class="">Herpes zoster ophthalmicus</p></li>
<li><p class="">Candida endophthalmitis</p></li>
<li><p class="">Toxoplasma retinochoroiditis</p></li>
<li><p class="">Herpes simplex infection</p></li>
<li><p class="">Molluscum contagiosum of lids <bold>(<a href="#ch14fig31" class="ulink-inter">Fig. 14.31</a>)</bold>.</p></li>
</ul></p></li>
</ul>
<div class="section" id="ch14lev2sec51"><h2 class="title">Management</h2>
<ul style="list-style-type: bullet">
<li><p class="">Zidovudine (azidothymidine) is seen to be effective in HIV retinitis.</p></li>
<li><p class="">In CMV retinitis—intravascular injection of <span class="italic">Gancyclovir</span> or <span class="italic">Foscarnet</span> may be effective.<a name="page246"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">246</span></span></p></li>
</ul>
<div class="figure" id="ch14fig31" data-label="Fig. 14.31"><div class="title"><span class="item-label">Fig. 14.31</span> Molluscum contagiosum in AIDS.</div><img alt="Fig. 14.31" src="/MediumImage/246-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig32" data-label="Fig. 14.32"><div class="title"><span class="item-label">Fig. 14.32</span> Endophthalmitis after cataract surgery.</div><img alt="Fig. 14.32" src="/MediumImage/246-2.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig33" data-label="Fig. 14.33"><div class="title"><span class="item-label">Fig. 14.33</span> Endogenous bacterial endophthalmitis.</div><img alt="Fig. 14.33" src="/MediumImage/246-3.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">Kaposi's sarcoma is sensitive to radiotherapy.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec23"><h1 class="title">ENDOPHTHALMITIS</h1>
<p class="noindent">It is a severe form of intraocular inflammation involving the ocular cavities and inner coats of the eyeball.</p>
<div class="section" id="ch14lev2sec52"><h2 class="title">Etiology</h2>
<div class="section" id="ch14lev3sec28"><h3 class="title">Infective</h3>
<p class="noindent">Most of the cases are infective in nature, which may be:</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Exogenous</span>
<ul style="list-style-type: square">
<li><p class="">Following penetrating injury.</p></li>
<li><p class="">Following intraocular surgery <bold>(<a href="#ch14fig32" class="ulink-inter">Fig. 14.32</a>)</bold>.</p></li>
<li><p class="">Following wound leak or bleb infection (after glaucoma surgery).</p></li>
<li><p class="">Spread from the adjacent structures, e.g., perforating corneal ulcer.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Endogenous:</span> Septic emboli from bacterial endocarditis <bold>(<a href="#ch14fig33" class="ulink-inter">Fig. 14.33</a>)</bold>, otitis media, meningitis, following urologic surgery, etc. (metastatic endophthalmitis). They are mainly seen in immune-compromized subjects.</p></li>
</ul>
<p class="noindent"><span class="italic">Common organisms include:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Bacteria:</span> <span class="italic">Staphylococci</span>, <span class="italic">Streptococci</span>, <span class="italic">Pneumococci</span>, <span class="italic">Pseudomonas</span>, <span class="italic">Bacillus subtilis</span>, <span class="italic">E</span>. <span class="italic">coli</span>, etc.</p></li>
<li><p class=""><span class="italic">Fungus:</span> <span class="italic">Candida</span>, <span class="italic">Aspergillus</span>, <span class="italic">Fusarium</span>, etc. <bold>(<a href="#ch14fig34" class="ulink-inter">Fig. 14.34</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Parasitic:</span> Toxocara.</p></li>
</ul>
</div>
<div class="section" id="ch14lev3sec29"><h3 class="title">Toxic (Sterile)</h3>
<ul style="list-style-type: bullet">
<li><p class="">Retained intraocular foreign body, e.g., pure copper.</p></li>
<li><p class="">Following IOL implantation (due to chemicals adherent to the implant).</p></li>
<li><p class="">Toxic reaction to the chemicals, adherent to the instruments (following chemical sterilization).</p></li>
<li><p class="">Necrosis of intraocular tumors.</p></li>
<li><p class="">Phacoanaphylactic uveitis leading to endophthalmitis.<a name="page247"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">247</span></span></p></li>
</ul>
<div class="figure" id="ch14fig34" data-label="Fig. 14.34"><div class="title"><span class="item-label">Fig. 14.34</span> Endogenous fungal endophthalmitis.</div><img alt="Fig. 14.34" src="/MediumImage/247-1.jpg"><div class="additional-markup"></div></div>
</div>
</div>
<div class="section" id="ch14lev2sec53"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class="">Usually unilateral with subacute onset.</p></li>
<li><p class="">Moderate pain and redness of the eye.</p></li>
<li><p class="">Photophobia and lacrimation.</p></li>
<li><p class="">Gross impairment of vision.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec54"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Lid edema.</p></li>
<li><p class="">Ciliary congestion and chemosis of the conjunctiva.</p></li>
<li><p class="">Keratic precipitates, aqueous cells and flare.</p></li>
<li><p class="">Vitreous is somewhat hazy which prevents clear view of the fundus.</p></li>
<li><p class="">Later, a yellowish-white reflex appears at the pupillary area indicating massive exudation in the vitreous.</p></li>
<li><p class="">Intraocular pressure is low and eyeball gradually shrinks to phthisis bulbi.</p></li>
<li><p class="">Sometimes, it may progress into panophthalmitis.</p></li>
<li><p class="">Ultimately, vision reduces to ‘no PL’.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec55"><h2 class="title">Management</h2>
<p class="noindent">It should be very energetic and prompt.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Aqueous or vitreous tap:</span> A vitreous tap gives a better yield than aqueous tap.
<ul style="list-style-type: square">
<li><p class="">Smear preparation for Gram-stain, Gimsa stain and potassium hydroxide mount.</p></li>
<li><p class=""><span class="italic">Inoculation in culture media:</span> Blood agar, chocolate agar and Sabouraud's media.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Intravitreal injections:</span> It is to be given within 6 hours to achieve maximum intra- ocular concentration of antibiotics.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Antibiotics:</span> Gentamicin (400 µg), cephazoline (2.25 mg), vancomycin (1.0 mg), ceftazidime (0.2 mg), amikacin (0.2 mg). Among these ceftazidime and vancomycin are mostly preferred.</p></li>
<li><p class=""><span class="italic">Antifungal:</span> Amphotericin B (5 µg) in case of suspected or proved fungal endophthalmitis.</p></li>
<li><p class=""><span class="italic">Steroids:</span> Dexamethasone (360 µg) may be added to antibacterial agent.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Antibiotic therapy:</span> Systemic (intravenous or intramuscular), topical, and subconjunctival or sub-Tenon injection, are employed.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Systemic:</span> (i) <span class="italic">Oral:</span> Ciprofloxacin—750 mg—1 g twice daily for 7 days, (ii) <span class="italic">Intra- venous:</span> Cephazoline—1 g 4 times daily.</p></li>
<li><p class=""><span class="italic">Topical:</span> Fortified tobramycin and moxifloxacin drops every 30 minutes.</p></li>
<li><p class=""><span class="italic">Sub-Tenon:</span> Gentamicin (40 mg) and cephazoline (125 mg) daily for 5–7 days.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Antifungal:</span> (i) <span class="italic">Systemic:</span> Oral ketoconazole or fluconazole is given for 4–6 weeks. (ii) <span class="italic">Topical:</span> Natamycin or amphotericin B (0.15%) drop is given every 30 minutes.</p></li>
<li><p class=""><span class="italic">Steroids:</span> They are indicated only in suspected bacterial endophthalmitis. Systemic (prednisolone—60 mg/day) and topical (dexamethasone 1 hourly).</p></li>
<li><p class=""><span class="italic">Subsequent therapy:</span> It is governed by the culture results.</p></li>
<li><p class=""><span class="italic">Vitrectomy:</span> Early vitrectomy is considered if the intravitreal injection fails to control endophthalmitis within 48–72 hours, and the vision is considerably reduce.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec24"><h1 class="title">TOXIC ANTERIOR SEGMENT SYNDROME (TASS)</h1>
<p class="noindent">TASS is a form of non-infectious acute intraocular inflammation accompanied by diffuse corneal edema within 12–48 hours of anterior segment surgery, especially after cataract operation <bold>(<a href="#ch14fig35" class="ulink-inter">Fig. 14.35A</a>)</bold>.<a name="page248"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">248</span></span></p>
<div class="figure" id="ch14fig35" data-label="Figs. 14.35A and B"><div class="title"><span class="item-label">Figs. 14.35A and B</span> <bold>A.</bold> TASS following endothelial keratoplasty; <bold>B.</bold> TASS-induced severe corneal edema.</div><img alt="Figs. 14.35A and B" src="/MediumImage/248-1.jpg"><div class="additional-markup"></div></div>
<p class="noindent">It is differentiated from acute infectious endophthalmitis which typically develops 2–5 days postoperatively. TASS is mostly responsive to frequent topical corticosteroids.</p>
<ul style="list-style-type: bullet">
<li><p class=""><bold>Causes:</bold> It is multi-factorial such as—bacterial endotoxins contamination of BSS or Ringer's lactate solution, denatured ophthalmic viscosurgical devices (OVDs), intracameral medications, inadequate flushing of instruments or tubings, preservatives, metallic precipitates from instruments, or even from powdered gloves.</p></li>
<li><p class=""><bold>Symptoms:</bold> Blurring of vision within 12–48 hours after surgery, mild to moderate pain, and photophobia.</p></li>
<li><p class=""><bold>Signs:</bold> Limbus to limbus corneal edema, severe A/C reactions may be with hypopyon, dilated pupil and increased IOP.</p></li>
<li><p class=""><bold>Investigations:</bold> USG B-scan to rule out any posterior reaction, i.e., acute endophthalmitis. Both aqueous and vitreous taps are sent for culture to rule out any infection.</p></li>
<li><p class=""><bold>Management:</bold> Most TASS patients respond well to 1% Prednisolone acetate eye drop given hourly. Mild cases respond rapidly within a week with topical steroids alone. In moderate to severe TASS, the clearing may take up to 4–6 weeks and may need systemic Prednisolone.</p>
<p class="">There may be permanent damage, such as—persistent corneal edema, fixed dilated pupil, refractory secondary glaucoma and cystoid macular edema.</p>
<p class="">In severe TASS with persistent corneal edema <bold>(<a href="#ch14fig35" class="ulink-inter">Fig. 14.35B</a>)</bold>—patients may require endothelial keratoplasty after control of inflammation. In some eyes, glaucoma surgery may be necessary before keratoplasty.</p></li>
<li><p class=""><bold>Prevention:</bold> The surgeon and the operating room staff should be well aware of the standard operating procedures (SOPs) against infection and TASS. Use of proper balanced salt solution (BSS), fresh OVDs, preservative-free intracameral medications, adequate precaution for cleaning instruments and tubings, and powder-free gloves—are the key to prevent TASS.</p>
<p class="">Prompt recognition of a TASS outbreak and identification of its source is crucial to prevent further cases.</p></li>
</ul>
</div><div class="section" id="ch14lev1sec25"><h1 class="title">PANOPHTHALMITIS (<a href="#ch14fig36" class="ulink-inter">FIGS. 14.36A AND B</a>)</h1>
<p class="noindent">This is the most severe form of inflammation of the ocular cavities which involves all three coats of the eyeball as well as the Tenon's capsule.</p>
<div class="section" id="ch14lev2sec56"><h2 class="title">Etiology</h2>
<p class="noindent">Same as endophthalmitis except the toxic causes. Panophthalmitis is mostly caused by bacterial infections.<a name="page249"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">249</span></span></p>
<div class="figure" id="ch14fig36" data-label="Figs. 14.36A and B"><div class="title"><span class="item-label">Figs. 14.36A and B</span> Panophthalmitis. A. Following cataract surgery; <bold>B.</bold> Following corneal ulcer.</div><img alt="Figs. 14.36A and B" src="/MediumImage/249-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch14lev2sec57"><h2 class="title">Symptoms</h2>
<ul style="list-style-type: bullet">
<li><p class="">Severe pain with radiation</p></li>
<li><p class="">Swelling of the eyelids</p></li>
<li><p class="">Complete loss of vision</p></li>
<li><p class="">Fever, malaise, headache, etc.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec58"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">No perception of light (no PL).</p></li>
<li><p class="">Marked lid edema.</p></li>
<li><p class="">Conjunctival chemosis and congestions.</p></li>
<li><p class="">Slight proptosis, and there may be limitation of movements.</p></li>
<li><p class="">Cornea is hazy and necrotic.</p></li>
<li><p class="">Anterior chamber is full of pus.</p></li>
<li><p class="">Intraocular tension is raised initially.</p></li>
<li><p class="">Globe may rupture at the limbus or at the pre-existing wound, and pus will come out at those places.</p></li>
<li><p class="">The signs may gradually subside, and the eye becomes a shrunken mass of fibrotic tissue (phthisis bulbi).</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec59"><h2 class="title">Complications</h2>
<ul style="list-style-type: bullet">
<li><p class="">Orbital and facial cellulitis</p></li>
<li><p class="">Cavernous sinus thrombosis</p></li>
<li><p class="">Meningitis or encephalitis.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec60"><h2 class="title">Treatment</h2>
<ul style="list-style-type: bullet">
<li><p class="">Medical treatment with intensive antibiotics is very rarely successful.</p></li>
<li><p class="">Evisceration of the eyeball is finally the treatment of choice <span class="italic">(see</span> <a href="/9789356963825/chapter/ch25" class="ulink-exter">Chapter 25</a>).</p></li>
<li><p class="">Enucleation is contraindicated.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec26"><h1 class="title">DEGENERATIONS OF UVEAL TRACT</h1>
<div class="section" id="ch14lev2sec61"><h2 class="title">Iridocorneal Endothelial (ICE) Syndromes</h2>
<p class="noindent">This is a spectrum of diseases of unknown etiology, essentially due to abnormalities in the corneal endothelium.</p>
<p class="indent">After metaplasia, the <span class="italic">corneal endothelium proliferates</span>, and <span class="italic">Descemet's membrane</span>-like material covers the anterior iris surface and angle of the anterior chamber, causing iris anomalies and secondary glaucoma.</p>
<p class="indent">These disorders are slowly progressive over a period of 10 years or more. Women are more commonly affected than men.</p>
<p class="noindent"><span class="italic">The spectrum includes three conditions:</span></p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Progressive essential iris atrophy (<a href="#ch14fig37" class="ulink-inter">Figs. 14.37A and B</a>)</span></p>
<ul style="list-style-type: square">
<li><p class="">It is a <span class="italic">unilateral</span> condition characterized by <span class="italic">patchy iris atrophy</span> with partial or complete hole formation.</p></li>
<li><p class="">There is distorted and displaced pupil <span class="italic">(corectopia)</span>.</p></li>
<li><p class=""><span class="italic">Holes in the iris (polycoria),</span> which may enlarge and coalesce together.<a name="page250"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">250</span></span></p>
<p class=""><div class="figure" id="ch14fig37" data-label="Figs. 14.37A and B"><div class="title"><span class="item-label">Figs. 14.37A and B</span> Essential iris atrophy—polycoria; corectopia and PAS.</div><img alt="Figs. 14.37A and B" src="/MediumImage/250-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Glaucoma</span> then ensues from peripheral anterior synechiae and from damage to the trabecular meshwork.</p></li>
<li><p class=""><span class="italic">Treatment</span> is directed toward secondary glaucoma, and is often, not effective either by medical or surgical means.</p></li>
</ul></li>
<li><p class=""><span class="italic">Iris nevus syndrome (Cogan-Reese)</span></p>
<ul style="list-style-type: square">
<li><p class="">Characteristic feature is dark brown pigmented nodules in the iris stroma (as small woolen spherules) <bold>(<a href="#ch14fig38" class="ulink-inter">Fig. 14.38A</a>)</bold>.</p></li>
<li><p class="">Peripheral anterior synechiae and secondary glaucoma may also occur.</p></li>
<li><p class=""><span class="italic">Treatment</span> is directed toward the control of secondary glaucoma.</p></li>
</ul></li>
<li><p class=""><span class="italic">Chandler's syndrome (<a href="#ch14fig38" class="ulink-inter">Fig. 14.38B</a>)</span></p>
<ul style="list-style-type: square">
<li><p class="">It is mainly associated with <span class="italic">endothelial disturbances and corneal edema</span>.</p></li>
<li><p class=""><span class="italic">Iris atrophy is minimal</span> and without a tendency to hole formation.</p></li>
<li><p class="">Peripheral anterior synechiae and <span class="italic">secondary glaucoma are less common</span>, and the control of glaucoma is easier.</p></li>
<li><p class=""><span class="italic">Penetrating or endothelial keratoplasty</span> may be considered for corneal edema.</p></li>
</ul></li>
</ol>
<div class="sidebar">
<h2 class="title">Iridoschisis</h2>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">It is a rare, diffuse, bilateral, senile degenerative condition of the iris. It may also be precipitated by trauma.</p></li>
<li><p class="">Large dehiscences appear on the anterior mesodermal layer of the iris and strands of tissue may float into the anterior chamber.</p></li>
<li><p class="">Treatment is not necessary.</p></li>
</ul></p>
</div>
<div class="figure" id="ch14fig38" data-label="Figs. 14.38A and B"><div class="title"><span class="item-label">Figs. 14.38A and B</span> <bold>A.</bold> Iris nevus syndrome; <bold>B.</bold> Chandler's syndrome.</div><img alt="Figs. 14.38A and B" src="/MediumImage/250-2.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page251"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">251</span></span></p>
</div>
</div><div class="section" id="ch14lev1sec27"><h1 class="title">RUBEOSIS IRIDIS (<a href="#ch14fig39" class="ulink-inter">FIG. 14.39</a>)</h1>
<p class="noindent">It means neovascularization of the iris. It occurs as an irregularly distributed network of new vessels on the iris surface and the stroma.</p>
<div class="section" id="ch14lev2sec62"><h2 class="title">Causes</h2>
<ul style="list-style-type: bullet">
<li><p class="">Diabetes mellitus</p></li>
<li><p class="">Central retinal venous occlusion</p></li>
<li><p class="">Heterochromic cyclitis of Fuchs</p></li>
<li><p class="">Carotid artery occlusive diseases</p></li>
<li><p class="">Intraocular tumors</p></li>
<li><p class="">Anterior segment ischemia</p></li>
<li><p class="">Following vitrectomy in aphakic eyes.</p></li>
</ul>
<p class="indent">The new blood vessels and associated fibrous tissue may cover the trabecular meshwork and cause peripheral anterior synechiae. These ultimately close the angle of the anterior chamber and cause an intractable neovascular glaucoma.</p>
</div>
<div class="section" id="ch14lev2sec63"><h2 class="title">Treatment</h2>
<p class="noindent">Neovascular glaucoma is difficult to treat.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Panretinal photocoagulation</span> is the treatment of choice in most cases. Photoablation of the neovascularized retina is followed by involution of iris vessels.</p></li>
<li><p class=""><span class="italic">Intravitreal anti-VEGF injections</span> may be tried to reduce retinal neovascularization.</p></li>
<li><p class=""><span class="italic">Panretinal cryocoagulation</span> helps similarly, especially in presence of opacity in the media (e.g., cataract or vitreous hemorrhage).</p></li>
<li><p class=""><span class="italic">Cyclocryotherapy</span> in resistant cases.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec28"><h1 class="title">CHOROIDAL DEGENERATIONS</h1>
<p class="noindent">As the outer layers of the retina receive their nourishment from the choriocapillaries, degeneration of the choroid is often associated with atrophy of the retina, and migration of pigments in the superficial retinal layers. Secondary degenerations occur following inflammatory lesions, myopia, or in late stages of glaucoma.</p>
<div class="section" id="ch14lev2sec64"><h2 class="title">Primary Choroidal Sclerosis (<a href="#ch14fig40" class="ulink-inter">Fig. 14.40</a>)</h2>
<p class="noindent">It is a degenerative vascular sclerosis of the choroid associated with secondary degeneration of the retina. It occurs as an isolated lesion and is not associated with generalized vascular sclerosis.</p>
<p class="noindent"><span class="italic">Pathologically</span>, the sclerosis is limited to the choriocapillaries and precapillary arterioles, and the veins are being less affected.</p>
<p class="noindent"><span class="italic">Ophthalmoscopy</span> shows diffuse atrophy of the retinal pigment epithelial (RPE) and choriocapillaries, and a tessellated appearance of the fundus. The larger sclerosed choroidal vessels are more visible as white lines against the irregular pigmented areas.</p>
<div class="figure" id="ch14fig39" data-label="Fig. 14.39"><div class="title"><span class="item-label">Fig. 14.39</span> Rubeosis iridis with ectropion uveae.</div><img alt="Fig. 14.39" src="/MediumImage/251-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch14fig40" data-label="Fig. 14.40"><div class="title"><span class="item-label">Fig. 14.40</span> Choroidal sclerosis.</div><img alt="Fig. 14.40" src="/MediumImage/251-2.jpg"><div class="additional-markup"></div></div>
<p class="noindent"><a name="page252"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">252</span></span><span class="italic">It occurs in two forms:</span></p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Diffuse or generalized sclerosis:</span> It affects the whole fundus. It may cause bilateral progressive diminution of vision, specially at night.</p></li>
<li><p class=""><span class="italic">Localized sclerosis:</span> It affects the central area or circumpapillary region and is also known as central areolar choroidal dystrophy. Central vision is gradually reduced with development of central scotoma.</p></li>
</ol>
</div>
<div class="section" id="ch14lev2sec65"><h2 class="title">Gyrate Atrophy of Choroid (<a href="#ch14fig41" class="ulink-inter">Fig. 14.41</a>)</h2>
<p class="noindent">This is an inherited (autosomal recessive), inborn error of amino acid metabolism due to defective activity of ornithine ketoacid amino transferase enzyme resulting in hyperornithinemia.</p>
<ul style="list-style-type: bullet">
<li><p class="">The <span class="italic">symptoms</span> include progressive dimness of vision with night blindness in young adults.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopy</span> shows, scalloped to circular patches of chorioretinal atrophy in the far and mid-retinal periphery. The patches increase in size and coalesce together, and finally, whole fundus is affected, with preservation only of the macula.</p></li>
<li><p class=""><span class="italic">Perimetry</span> shows, constriction of the peripheral visual field corresponding to the extent of fundus lesion.</p></li>
<li><p class=""><span class="italic">Treatment:</span> A diet low in proteins and arginine (precursor of ornithine) may be beneficial.</p></li>
</ul>
<p class="indent">Massive doses of pyridoxine (vitamin B<sub>6</sub>) normalize the hyperornithinemia and may have beneficial effect on the ocular lesion.</p>
<div class="figure" id="ch14fig41" data-label="Fig. 14.41"><div class="title"><span class="item-label">Fig. 14.41</span> Gyrate atrophy of the choroid.</div><img alt="Fig. 14.41" src="/MediumImage/252-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch14lev2sec66"><h2 class="title">Choroideremia</h2>
<p class="noindent">It is an inherited (X-linked recessive) choroidal atrophy with secondary atrophy of the retina, resulting in night blindness.</p>
<ul style="list-style-type: bullet">
<li><p class="">The disease characteristically affects only males and starts within 5–10 years of age with defective night vision.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopy</span> shows, diffuse mottled depigmentation of the RPE. Eventually, large patches of chorioretinal atrophy develop in the equatorial region. The atrophy then spreads centrally and peripherally, with annular scotoma and progressive constriction of the visual field. Central vision is last to be affected.</p></li>
</ul>
<p class="noindent">The retinal vessels are characteristically normal.</p>
<ul style="list-style-type: bullet">
<li><p class="">Female carriers often clinically show mild fundus changes (patchy atrophy and mottling of the RPE at the equator), though they are asymptomatic.</p></li>
<li><p class="">No treatment is available.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec67"><h2 class="title">Angioid Streaks (<a href="#ch14fig42" class="ulink-inter">Fig. 14.42</a>)</h2>
<p class="noindent">Angioid streaks are irregular and jagged network of red to brown lines, mainly seen in the central fundus.</p>
<ul style="list-style-type: bullet">
<li><p class="">They are produced by crack-like dehiscences in the collagenous and elastic portion of the Bruch's membrane.</p></li>
<li><p class="">The streaks or lines typically radiate outward in a tapering fashion from the peripapillary area.</p></li>
<li><p class="">The lesions are approximately the width of a retinal vessel, which may thus resemble (angioid). But the streaks are darker, have an irregular contour with serrated edges, and tend to terminate abruptly.<a name="page253"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">253</span></span></p></li>
</ul>
<div class="figure" id="ch14fig42" data-label="Fig. 14.42"><div class="title"><span class="item-label">Fig. 14.42</span> Angioid streak.</div><img alt="Fig. 14.42" src="/MediumImage/253-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Systemic associations</span>
<ul style="list-style-type: square">
<li><p class="">Pseudoxanthoma elasticum (Grönblad–Strandberg syndrome)—most common.</p></li>
<li><p class="">Paget's disease</p></li>
<li><p class="">Ehlers–Danlos syndrome</p></li>
<li><p class="">Sickle cell disease</p></li>
<li><p class="">Rarely, acromegaly, hypercalcemia and lead poisoning.</p></li>
</ul></p></li>
<li><p class="">Ocular changes are normally asymptomatic. The causes of visual impairment may be due to:
<ul style="list-style-type: square">
<li><p class="">Involvement of the fovea by a streak,</p></li>
<li><p class="">Choroidal neovascularization, or</p></li>
<li><p class="">Choroidal rupture.</p></li>
</ul></p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec68"><h2 class="title">Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)</h2>
<ul style="list-style-type: bullet">
<li><p class="">It is a rare, bilateral, idiopathic disease affecting the young adults.</p></li>
<li><p class="">The <span class="italic">primary site of lesion</span> is at the level of RPE, although it has also been suggested as a <span class="italic">vasculopathy</span> of the choriocapillaries.</p></li>
<li><p class="">Initially, the <span class="italic">patient presents</span> with a subacute loss of central vision, and within a few days the fellow eye is usually affected.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopy</span> shows, the typical deep, cream colored placoid lesions, involving the posterior pole within the equatorial region.</p></li>
<li><p class=""><span class="italic">Fundus fluorescein angiography</span> shows patchy irregular choroidal filling with late staining.</p></li>
<li><p class="">Spontaneous resolution with good visual recovery is usual, within a few weeks.</p></li>
<li><p class="">There is no <span class="italic">effective treatment</span>.</p></li>
</ul>
</div>
<div class="section" id="ch14lev2sec69"><h2 class="title">Serpiginous (Geographical) Choroidopathy</h2>
<p class="noindent">It is a rare, idiopathic, recurrent disease of the RPE and choriocapillaries affecting the middle-aged patient.</p>
<ul style="list-style-type: bullet">
<li><p class="">Initially, the patient remains asymptomatic.</p></li>
<li><p class="">The chorioretinal lesion usually starts around the optic disc, and spreads outwards in all directions.</p></li>
<li><p class=""><span class="italic">Acute lesions</span> are cream colored opacities with hazy border without any inflammatory cells in the vitreous.</p></li>
<li><p class="">With healing, they become inactive, leaving scalloped ‘punched out’ areas of chorioretinal atrophy.</p></li>
<li><p class="">Fresh acute lesions usually arise as extensions from old scars, and successive attacks result in serpiginous extension of the destruction process peripherally from the peripapillary area.</p></li>
<li><p class="">Involvement of the fovea causes a permanent loss of central vision.</p></li>
<li><p class="">Fluorescein angiography confirms the diagnosis.</p></li>
<li><p class="">There is no <span class="italic">effective treatment</span>.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec29"><h1 class="title">CHOROIDAL DETACHMENT (<a href="#ch14fig43" class="ulink-inter">FIG. 14.43</a>)</h1>
<p class="noindent">It means separation of the choroid from the sclera which occurs frequently.</p>
<div class="section" id="ch14lev2sec70"><h2 class="title">Causes</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Following intraocular operations:</span> Sudden lowering of intraocular pressure → vasodilatation of the choroidal vessels → exudation on to the outer lamella of the choroid → detachment</p></li>
<li><p class="">Following intraocular hemorrhage</p></li>
<li><p class="">Choroidal tumors</p></li>
<li><p class="">Exudative choroiditis.<a name="page254"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">254</span></span></p></li>
</ul>
<div class="figure" id="ch14fig43" data-label="Fig. 14.43"><div class="title"><span class="item-label">Fig. 14.43</span> Choroidal detachment with retinal detachment (kissing choroidals).</div><img alt="Fig. 14.43" src="/MediumImage/254-1.jpg"><div class="additional-markup"></div></div>
<p class="indent">Photopsia and floaters (as seen in retinal detachment) are absent.</p>
</div>
<div class="section" id="ch14lev2sec71"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class="">Shallow anterior chamber.</p></li>
<li><p class="">Intraocular pressure is very low as a result of hyposecretion of aqueous due to a concomitant ciliary body detachment.</p></li>
<li><p class="">It may be visible as dark brown mass by oblique illumination after mydriasis.</p></li>
<li><p class=""><span class="italic">Ophthalmoscopy</span> shows smooth, elevated, darkbrown bullous lesions, which are more prominent on the temporal and nasal sides.</p></li>
</ul>
<p class="indent">The elevations do not extend to the posterior pole because they are limited by the adhesions, where the vortex veins enter their scleral tunnels.</p>
</div>
<div class="section" id="ch14lev2sec72"><h2 class="title">Treatment</h2>
<p class="noindent">The prognosis is usually good. The choroid is reattached, and anterior chamber is reformed, without any treatment. However, in some persistent cases, it requires treatment.</p>
<ul style="list-style-type: bullet">
<li><p class="">Corticosteroids drop and posterior sub-Tenon injection of triamcinolone may be useful in some eyes. Tablet acetazolamide, 250 mg 4 times daily.</p></li>
<li><p class="">To look for ‘wound leak’ and if it is there—treatment is done by regular patching or conjunctival flap or resuturing.</p></li>
<li><p class="">In recalcitrant cases, drainage of the subchoroidal fluid through a diathermy puncture at the most prominent site of detachment has been suggested.</p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec30"><h1 class="title">IRIS CYSTS</h1>
<p class="noindent">Iris cysts are not very uncommon, and they may be <span class="italic">primary</span> or <span class="italic">secondary</span>.</p>
<div class="section" id="ch14lev2sec73"><h2 class="title">Primary Iris Cysts (<a href="#ch14fig44" class="ulink-inter">Figs. 14.44A and B</a>)</h2>
<ul style="list-style-type: bullet">
<li><p class="">They usually arise from the iris pigment epithelium and very rarely, from the iris stroma.</p></li>
<li><p class="">Those arising from the pigment epithelial layer, are stationary and asymptomatic.</p></li>
<li><p class="">They are globular, dark brown structures which transilluminate.</p></li>
<li><p class="">Treatment is required in selected cases if it touches the cornea.</p></li>
</ul>
<div class="figure" id="ch14fig44" data-label="Figs. 14.44A and B"><div class="title"><span class="item-label">Figs. 14.44A and B</span> <bold>A.</bold> Primary iris cysts; <bold>B.</bold> Same in slit section.</div><img alt="Figs. 14.44A and B" src="/MediumImage/254-2.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page255"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">255</span></span></p>
<div class="figure" id="ch14fig45" data-label="Figs. 14.45A and B"><div class="title"><span class="item-label">Figs. 14.45A and B</span> Secondary iris cyst. <bold>A.</bold> Post-cataract surgery; <bold>B.</bold> Translucent in slit section.</div><img alt="Figs. 14.45A and B" src="/MediumImage/255-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch14lev2sec74"><h2 class="title">Secondary Iris Cysts (<a href="#ch14fig45" class="ulink-inter">Figs. 14.45A and B</a>)</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Implantation cysts:</span> They develop from implantation of epithelial cells on to the iris following intraocular surgery or penetrating injury.
<ul style="list-style-type: square">
<li><p class="">The cysts lie on the anterior surface of the iris, and grayish white in color.</p></li>
<li><p class="">They frequently enlarge and lead to complications, like anterior uveitis and glaucoma.</p></li>
<li><p class=""><span class="italic">Surgical excision</span> is the treatment of choice.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Drug-induced iris cysts:</span> They occur following prolonged use of long-acting miotics, such as phospholine iodide.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Treatment:</span> Withdrawal of the drug and simultaneous use of phenylephrine (2.5%) with long-acting miotic, prevents formation of the iris cysts.</p></li>
</ul></p></li>
</ul>
</div>
</div><div class="section" id="ch14lev1sec31"><h1 class="title">TUMORS OF THE UVEAL TRACT</h1>
<p class="noindent"><span class="italic">See</span> <a href="/9789356963825/chapter/ch20" class="ulink-exter">Chapter 20</a>.</p>
</div></div></div>